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The work in this thesis was undertaken between October 1996 and August 1999 
and is primarily concerned with the design and synthesis of novel antioxidants. 
These compounds could prove useful in the treatment of conditions such as 
atherosclerosis and diabetes where lipid peroxidation plays an important role.
The syntheses of some novel carbazoles and piperidinotetrahydroquinolines are 
described. An important step encountered throughout the course of the research 
involves the addition of alkyl lithiums to indoleines. The reaction was thus studied 
using a variety of nucleophiles with particular reference to the selectivity of the 
additions. Evidence was gained to believe that this may not be a simple two 
electron but rather a single electron transfer.
Attention was then turned to electrochemistry in an attempt to try and mimic the 
results obtained by chemical reduction of alkali metals.
The final part of the thesis involves the synthesis of some compounds where the 
problems of chirality have been eliminated.
Background
Free radicals of various types are responsible for a broad range of diseases such as 
atherosclerosis and diabetes. One possible explanation for the induction of these 
diseases is that the endogenous antioxidants, which normally protect against radical 
damage, are not sufficiently active to prevent tissue impairment. Lipid 
peroxidation caused by the generation of excess radical species may constitute one 
significant damaging pathway in the above diseases. Administration of 
antioxidants (additional to those from dietary intake) are currently of interest since 
they may act to supplement and improve natural protection against attack by
radical species such as superoxide ^  “3.
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1.0 Introduction
1.1 Cholesterol and Atherosclerosis
Since its isolation, from gall stones in 1784, cholesterol (1) has become of great 
importance medicinally. On the one hand it is fundamental to mammalian 
existence, but on the other hand it has an association with heart disease. 
Cholesterol is a hydrophobic steroid; it has one hydroxy group and one double­
bond, together with a side chain of eight carbon atoms.
HO
(1)
Cholesterol serves several vital functions in the body. It is an essential component 
of all cell membranes, providing stability and allowing for transmembrane 
transport. It is important in the biosynthesis of bile acids, which are produced in 
the liver and participate in the absorption of fat in the intestine.
1.2 Transport of cholesterol in the body
Cholesterol is highly insoluble in aqueous systems and for this reason it cannot 
circulate freely in plasma. Instead, it is transported around the body in complex 
particles called lipoproteins.
The basic structure of all lipoproteins are similar. They all contain a core of neutral 
lipids consisting of cholesterol esters and triglycerides and are surrounded by a 
surface coat of more polar lipids, which include unesterified cholesterol,
phospholipids and proteins known as apoproteins. The surface coat of the 
lipoproteins provides a covering structure that resembles the typical plasma 
membrane of cells, within this the lipids serve as an interface between the aqueous 
plasma and the inner non-polar lipid core. The lipoprotein is therefore soluble in 
aqueous media such as serum and can be transported around the circulatory system 
to areas of the body where it is required.
There are five distinct types of lipoprotein. Each lipoprotein is made up of a 
different combination of fats and proteins. All five lipoproteins have special 
functions, with different significance for the formation of arterial plaques and the 
development of coronary heart disease (CHD).
• Chylomicrons.
The transport of cholesterol from the intestine to the liver is facilitated by 
lipoproteins called chylomicrons. These particles are synthesized in the mucosal 
cells of the intestine, and are then transported through the lymphatic system until 
they reach the thoracic duct, where they drain into the bloodstream. Here, the 
triacylglycerol components are hydrolysed by the enzyme lipoprotein lipase and are 
either taken up by adipose tissue for storage, or by muscle tissue for oxidation to 
supply energy. The cholesterol enriched chylomicron remnants are then removed 
from circulation by liver cells.
• Very low density lipoprotein (VLDL).
The major lipoprotein synthesized by the liver is VLDL. VLDL particles transport 
endogenously produced triglycerides and some cholesteryl esters from the liver. 
VLDL remnants are either taken up by the liver or transformed into low density 
lipoproteins (LDL).
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• Intermediate density lipoprotein (IDL).
When VLDL particles reach adipose or muscle tissue triglycerides are released, 
leaving a particle decreased in size, but enriched in cholesteryl esters. These 
residual assemblies are called IDLs. Approximately half of the DDLs in circulation 
are removed 2 - 6  hours after their initial formation by liver cells. Within these 
cells, cholesterol is extracted to make new VLDLs and bile acids. IDLs not taken 
up by the liver dissociate to form LDL particles.
• High density lipoproteins (HDL).
HDL units are responsible for the transport of cholesterol from the tissues back to 
the liver. This is achieved by converting the steroid into cholesteryl esters, some of 
which are taken up by the mobile VLDLs and some absorbed directly by the liver.
• Low density lipoprotein (LDL).
In human blood, the major cholesterol-carrying lipoprotein of plasma is LDL. A 
conjectural structure of a LDL particle is shown in [Figure (1)]. It consists of a 
lipid core composed of about 1500 molecules of cholesterol esters. The surface 
coat of LDL contains unesterified cholesterol and phospholipids together with a 
single apoprotein apo B-100. LDL can be removed from the bloodstream either 
via the liver or extrahepatic tissues. Uptake of LDL by either route can occur 





DIAMETER: 2 2 5 -2 7 5  A
Figure (1). Reproduced by permission from S.M. Grundy, Cholesterol and 
Atherosclerosis, 1st ed., Gower Medical Publishing, New York, 1990 ©.
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Figure (2). Reproduced by permission from S.M. Grundy, Cholesterol and
Atherosclerosis, 1st ed., Gower Medical Publishing, New York, 1990 ©.
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1.3 LDL receptors
LDL receptors were first discovered in 1973 by Brown and Goldstein 4 when they 
were studying tissue cultures of the human skin cells called fibroplasts. Although, 
the actual structure of the LDL receptor is still a matter of some debate, a 
schematic representation can be made [Figure (2)]. The LDL receptor consists of 
820 amino acids and a series of carbohydrate units with a total molecular weight in 
the region of 120,000. The receptor has been shown to possess several domains, 
each of which has a unique function. Only one domain is responsible for binding 
LDL to the plasma membrane of the cell. The central role of the LDL receptor in 
atherosclerosis was first appreciated when Goldstein and Brown showed that its 
absence is responsible for the severe disease called familial hypercholesterolemia 
(FH).
1.4 Receptor-Mediated Clearance of LDL
The pathway by which fats are metabolized and transported around the body is 
very complex. However, the mechanism by which LDL is metabolized was finally 
elucidated in 1985 by Brown and Goldstein; an achievement for which they
received a Nobel p rized
The mechanism of LDL uptake by cells is shown in [Figure (3)]. LDL receptors 
are located in coated pits on the surface of cell membranes. When they bind to a 
LDL particle, the cell membrane fuses in the area of the LDL-receptor complex to 
form membrane bound sacs. These are then delivered to lysosomes, which contain 
digestive enzymes that hydrolyze the apoprotein components into amino acids, and 
the cholesteryl esters to free cholesterol. The receptor is then transferred back to
6
the cell membrane for further use. Most of the liberated cholesterol moves to the 
endoplasmic reticulum, where it is used for membrane synthesis. An accumulation 
of cholesterol has three regulatory effects:
i) It reduces the synthesis of cholesterol by the cell by inhibiting the action of
3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA), and also by 
suppressing the synthesis of this enzyme itself.
ii) It activates the enzyme acyl-CoA : cholesterol acyl transferase (ACAT), 
which attaches fatty acid chains to excess cholesterol to form cholesteryl 
esters. These are then deposited in storage droplets.
iii) The most significant effect that an accumulation of cholesterol has is the
inhibition of LDL receptor synthesis by the cell. The cell thus adjusts so 
that it has enough receptors to get the cholesterol it requires, but not so 
many as to overload it. Excess cholesterol is therefore left in the 




Figure (3). Reproduced by permission from S.M. Grundy, Cholesterol and
Atherosclerosis, 1st ed., Gower Medical Publishing, New York, 1990 ©.
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1.5 Formation of an atherosclerotic plague bv LDL
Atherosclerosis develops slowly and is instigated by damage to the endothelium of
arteries. According to the original model proposed by Ross and Glomset^, the 
damaged endothelium becomes “leaky” and is penetrated by LDL particles and 
blood platelets. In response to the release of hormones such as platelet-derived 
growth factor, smooth muscle cells in the layer below the endothelium multiply and 
migrate into the damaged area. At the same time white blood cells, known as 
monocytes, migrate to the area and are activated to become scavenger cells called 
macrophages [Figure (4)]. Macrophages are large cells capable of ingesting 
foreign particles. Normal macrophages possess some LDL receptors, but if LDL is 
peroxidised (Section 1.6) it is recognized by other receptors known as the acetyl- 
LDL receptors or the scavenger receptors. LDL bound to these receptors is taken 
up with enhanced efficiency, so that cholesterol rapidly accumulates within the 
macrophage and may convert to a foam cell [Figure (5)]. Once formed, the foam 
cells enter the arterial wall and accumulate together with lipids. This causes 
necrosis of some foam cells, such that cholesterol esters are released and form a 
lipid core.
In the coronary arteries the smooth muscle cells and fibrous tissues have a 
tendency to cover the lipid and foam cell core, giving rise to a fibrous plaque 
[Figure (6)]. Fibrous plaques encourage the accumulation of blood clots and 
subsequent hemorrhaging into the plaque causes it to rupture. Following rupture, 
platelets may aggregate and increase the size of the obstruction. When the plaque 
grows too large vascular occlusion occurs and this leads to a lack of blood supply 
to the heart and myocardial infarction. This myocardial infarction maybe fatal 
leading to cardiac failure, alternatively recovery or part recovery is possible.
Several lines of evidence implicate oxidatively-damaged LDL in atherogenesis. 
Lipoproteins with many characteristics of oxidative damage have been isolated
from atheroma6. Several chemically-unrelated antioxidants, which are potent 
inhibitors of lipoprotein lipid peroxidation in vitro, retard atherogenesis in animal
models of hypercholesterolemia^, In vitro work demonstrates that extensively
oxidized LDL is rapidly taken up and degraded by cultured macrophages^^, 
suggesting a role for LDL oxidation in lipid accumulation by the arterial wall. 
Oxidized LDL is strongly cytotoxic, perhaps explaining why cellular necrosis is 
prominent in advanced atherosclerotic lesions.
• ■ ■ • ' .  • ••  ■ 
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Figure (4). Reproduced by permission from S.M. Grundy, Cholesterol and 
Atherosclerosis, 1st ed., Gower Medical Publishing, New York, 1990 ©.
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Figure (6). Reproduced by permission from S.M. Grundy, Cholesterol and
Atherosclerosis, 1st ed., Gower Medical Publishing, New York, 1990 ©.
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1.6 Lipid peroxidation
Lipid peroxidation has been broadly defined by A.L.Tappel as the “oxidative 
deterioration of polyunsaturated lipids”. Lipid peroxidation, such as that which 
occurs to form modified LDLs, is mainly caused by two species present in the 
body:
(1) The hydroxyl radical, OH
This is formed by the reaction of hydrogen peroxide with iron or copper ions:
H20 2 + Fe2+ --------► Fe3++ HO* + OH"
n p 2 + Cu+ --------► Cu2V  HO* + OH"
Scheme (1)
Copper is present in the body as part of the proteins albumin and histamine, while 
iron is an essential component of haem, the oxygen carrying component of red 
blood cells.
(2) The superoxide radical anion, O2
This species is produced along with hydroxyl radicals as a result of enzyme 
catalyzed reactions and by the action of phagocytes. Exposure of cells to ionizing 
radiation, such as X-rays and y-rays, can also produce the superoxide radical anion.
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(3) Initiation and propagation
The peroxidation process essentially proceeds via a free radical mechanism, which 
consists of initiation and propagation stages. The first chain intiation step in a 
membrane or polyunsaturated fatty acid is caused by a species that can abstract a 
hydrogen atom from a methylene group especially when it is adjacent to a double 
bond (i.e. an allylic system). The hydroxyl radical is able to do this.
By contrast, a superoxide anion is insufficiently reactive to abstract a proton from 
lipids, however, once the radical anion is protonated the reaction may proceed.
The presence of double bonds in lipids weakens the adjacent C-H bonds, thus 
making hydrogen abstraction easier. The resulting allyl radical is then stabilised by 
resonance to form a conjugated diene. Under aerobic conditions the conjugated
•










Propagation then occurs by the abstraction of a hydrogen atom from another lipid 
methylene group. The resulting carbon radical can react with oxygen, thus forming 
another peroxyl radical and hence a chain reaction.
ry %  + X  — ► r t ° ' oh + Ry H
R R R
Scheme (4)
Other reactions include formation of a cyclic peroxide from the peroxy radical, 
through attack at a P-double bond. The product may then fragment to form 
aldehydes and other products [Scheme (5)]:
o — o




A summary of one overall reaction is given below:
■H* hydrogen abstraction
0 2 oxygen uptake
peroxy radical abstracts H 
jj* from another fatty acid 




If oxidants do indeed initiate atherosclerosis, or contribute to its pathology, then an 
increased intake of antioxidants (in particular lipid soluble chain-breaking 
antioxidants that accumulate in lipoproteins) might be expected to have a beneficial 
effect.
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1.7 Autoxidation and Antioxidants
Autoxidation is the process by which chemical compounds react with molecular 
oxygen. With certain functionality this oxidation is particularly facile, leading to 
the breakdown of the substrate and the generation of peroxides [Section(1.6)]. 
Autoxidation is responsible for the deterioration of many manufactured plastic and 
rubber goods. Most susceptible to autoxidation are fats. Fats are present to a 
large extent in virtually all foods. Indeed, prevention of autoxidation is vital and 
countless synthetic antioxidants have been developed for this purpose.
A good antioxidant should fulfil several criteria. It must be effective as an electron 
or hydrogen donor; the resulting radical must be sufficiently stabilized so that the 
electron density of the unpaired electron is not localized, and thus reactive towards 
chain transfer. Similarly the radical should be sterically hindered for maximum 
effect; the original species must be stable towards autoxidation itself; and finally for 
many radical applications the compound must be sufficiently lipid soluble so that it 
is concentrated in areas where it is most effective.
Most antioxidants are phenols or aromatic amines and usually act via a chain- 
breaking mechanism [Section (1.8)]. They efficiently donate a hydrogen atom to a 
peroxy or alkoxy radical forming stable radicals, so interfering with the 
propagation of lipid peroxidation
Ar-OH + R 02’(RO’) Ar-O* + R 02H (ROH)
Ar-NH2 + R 02'(R0’) -> Ar-NH + R 02H (ROH)
Scheme (6)
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The nitrogen or oxygen centered antioxidant radical so produced is insufficiently 
reactive to abstract hydrogen from the substrate because of delocalisation of the 
unpaired electron into an aromatic ring moiety. Instead, both species act as chain 
terminating agents unless a mechanism exists for their reduction back to the 
antioxidant.
1.8 Vitamin E
Perhaps the best known phenolic antioxidant is a-tocopherol, the major constituent 




The lipophilic side chain of a-tocopherol ensures that the antioxidant will 
concentrate in the interior of membranes and be transported in lipoproteins, 
particularly by LDL. a-Tocopherol protects against lipid peroxidation by 
quenching and reacting with singlet oxygen and also by reducing the superoxide 
radical anion. The steps in the oxidation of a-tocopherol is shown in Scheme (7), 
and the mechanism by which the a-tocopheryl radical is regenerated in vivo by 
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Scheme (8)
A synergism between vitamin E and vitamin C (ascorbic acid) in trapping free 
radicals was first suggested by Tappel in 1968. Studies by Slater’s group 
confirmed that ascorbic acid can reduce the a-tocopheryl radical back to a- 
tocopherol [Scheme (8)] and this reaction has since been shown to occur in intact 
membranes. Thus, addition of ascorbate to membranes containing vitamin E can
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have antioxidant as well as pro-oxidant effects. Reduction presumably occurs 
close to the membrane surface, since it is unlikely that the polar vitamin C molecule 
can enter the hydrophobic interior.
1.9 Previous research
Chain-breaking antioxidants, such as vitamin E and its analogues, have been shown 
to be effective agents in the protection of biological tissue from oxidative stress 
12 Moreover, during the last decade several in vitro and in vivo studies 
suggest that modification of LDL by lipid peroxidation increases their atherogenic
properties^. This hypothesis is further supported by numerous in vitro studies 
showing that antioxidants, including vitamin E, can inhibit LDL oxidation, induced
by cells or metal ions^.
The potential beneficial therapeutic effects of potent inhibitors of lipid peroxidation 
encouraged Sainsbury and co-workers to develop novel compounds which when 
tested in vitro should be more potent than vitamin E. Initially our group sought to 
improve the selectivity exhibited by probucol (3), 2,2-bis(3,5-di-fer/-butyl-4- 
hydroxyphenylthio)propane a drug introduced by Marion Merell Dow as a LDL- 
cholesterol lowering agent.
American and Japanese scientists have found that the anti-atherogenic effect of 
probucol in rabbits is far greater than expected from its cholesterol-lowering 
ability. This suggested that its antioxidant activity may work by inhibiting the local 
oxidative modification of LDL in the arterial wall. Indeed, when administered to 
human plasma, 45% of this compound was found to bind to LDL and 15% to
VLDL15. The residual 40% was assumed to be retained by other lipids, including 
HDL and proteins. Although probucol was indeed effective, the search for a new 
lead compound continued. For example it was hoped that the next generation of 
compounds would not bind to HDL, since HDL is considered to be responsible for 
the transport of cholesterol to the liver, where it is degraded. Interference with this
process would not be beneficial^.
Before any compounds were synthesized at Bath, it was necessary to recognise 
what important attributes are likely to be required for such a chain breaking 
antioxidant.
From numerous studies, it was concluded that the ideal candidate should possess 
the following features:
(a) an aromatic “head” bearing substituents to determine an oxidation potential 
of approximately +0.4V.
(b) a lipophilic tail capable of “anchoring” the antioxidant in the artery wall so
that the head can intercept invasive radical species in the blood stream.
(c) possible regeneration of the “spent” antioxidant by vitamin C.
The first compounds to be studied by our g roups were the indenoindoles (4), the 







All of these compounds readily form radical cations and, by deprotonation at 
nitrogen, give radicals delocalised by the aromatic ring bonded to the NH group. 
Lipophilicity is then provided by the other fused rings. It should be noted that 
much substitution about the locus of oxidation is needed to prevent the radical 
being quenched by attack by other endogeneous radical species.
Although all these compounds were found to be- very potent antioxidants, • 
unfortunately they failed to show selective binding to LDL. This was considered 
to be essential if arterial plaque deposition was to be inhibited. There is some 
evidence to suggest that the lipophilic phytyl group of the natural antioxidant 
vitamin E locates the latter to LDL in this way. The lack of selectivity was a 
problem and since the lipophilic nature of the steroids is well established, Sainsbury
and c o - w o r k e r s  17 synthesized a series of indolines fused to commonly available 






This and other indolinosteroids certainly bound well to lipoproteins, much better 
than, say, the indenoindoles, but there was little differentiation between the various 
forms. Thus a significant incorporation into HDL was observed. It will be recalled 
that HDL is considered beneficial, so that inhibition of its normal function was 
undesirable. These results necessitated a re-evaluation of indolines with lipophility 
rankings intermediate between that of the steroidal derivatives and the simple 
indenoindoles.
Eventually the problem of selective incorporation was solved, by the synthesis of 
the indolenines (8-10) (R -Pr and R-Bu). These compounds react with 
alkyllithiums, thereby affording a-substituted indolines. By selecting alkyllithiums 
of varying lipophilicity a series of products with a range of LDL affinities were
formed and tested. The best com pounds^  obtained in this series were the 6-(NyN- 
dibenzylamino)hexyl derivative (8) (R-Pr) and the ethers (9) (R=tBu) and (10) 
(R-Bu).
H  X
X = (C H 2) 6N B u2 (8)
X = (C H 2)40(C H 2)60 P h (9 )
x= (CH o^ph (io)
These indolines were found to show better selectivity and percentage binding 
values than probucol. For example, the first compound (8) has a very high LDL 
incorporation value of 75%, while 10% is retained in VLDL. For the ethers (9) 
(R-Bu) and (10) (R-Bu) the values are 60 and 10% and 55 and 15%, 
respectively.
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A related compound^ (11) showed 30% binding to LDL and 20% binding to 
HDL.
(11)
For various reasons this compound, although not the best, was selected by Astra 
Pharmaceuticals for pre-clinical evaluation. Watanbe rabbits, which have a severe 
disposition to atherosclerosis, were fed a diet containing the antioxidant (11) over 
several weeks. They were then sacrificed and examined, but insufficient reduction 
of arterial plaque development was noted to warrant further testing. It must be 
said, however, that this disappointing result was none too reliable as the Watanbe 
rabbit is a very poor mimic of the human condition. There are other animal modes, 
but in the case of small mammals it is hard to determine the progression of plaque 
growth in tiny arteries. Larger animals are expensive to maintain besides raising 
many other difficulties, not least ethical ones. For this reason rabbits are still the 
animals of choice, but as just indicated the results are notoriously hard to interpret. 
In the Swedish trial the degree of plaque inhibition was less than that shown by 
probucol and this was enough to discourage further interest in the project-at least 
by Astra!. One overwhelming feature of most of the compounds submitted for 
assessment is the presence of at least one chiral centre. Only in the case of one 
indenoindole, synthesised very early on by a previous worker was resolution




l,2,3,4,4a,5,6,7-Octahydro-ll-isopropyl-l//-benzo[d]carbazole (12) can be 
regarded as the starting point for a series of antioxidants. Such a compound 
embodies the same type of oxidisable indole/indolinene ‘head* as the related 
dihydro and tetrahydroindenoindoles described earlier and its structure is fully 
substituted at C-3 of the indole unit. This feature would ensure that substitution at 
this position does not occur in the radical cation, or radical, formed after oxidation. 
Secondly, the imine group can be used as a means of substituting a range of groups 
with varying lipophilicity so that the overall affinity of the antioxidant so formed to 




Indeed, antioxidants (13) have already been synthesised at Bath from the addition 
of various alkyllithiums to the imine bond of the indolenine (12). Apart from the 
very low yields in these reactions, another problem with the products as 
antioxidants is that the C-9 position is unsubstituted. This allows the possibility 
that the ensuing radical cation, or radical, could be quenched by attack at this site 
by a nucleophile or a radical, respectively. Since the whole point of forming a
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chain-breaking antioxidant hinges upon the stability of its oxidised form this is a 
very serious matter and one that must be addressed.
One approach would be to use a 2,4-disubstituted phenylhydrazine in the Fischer 
indolisation reaction, thus to form a 9-substituted indolenine. In fact, two 
syntheses of this type have already been attempted by Dr A. Ninan in this 
Department, but even in the hands of such an experienced chemist the yields were 
very poor.
It became one of the author’s objectives to see if it was possible to improve 
matters by substituting the mono-substituted indolenine (12) directly at C-9. In 
addition, we decided to investigate the possibility of using imine-enamine 
tautomerism to functionalise C-7 and make this alternative anchor point for 
lipophilic units [Scheme (9)].
Scheme (9)
In order to advance both of these objectives it was necessary to synthesise a stock 
of (12) using the Fischer indolisation of fraras-l-decalone. Unfortunately, this 
ketone has two a-hydrogens. Both can become involved in the ring-closing 
reaction of the intermediate hydrazone formed with 4-isopropylphenylhydrazine 
[Scheme (10)].
Scheme (10)
This is a well known problem with unsymmetrical ketones. In 1978 Miller and
Schinske^ noted that phenylhydrazones of 2-substituted cyclohexanones gave 
both indoles and indolenines when reacted with dilute sulfuric acid. Early 
i n v e s t i g a t i o n s 2 0 - 2 3  suggest that the course of the reaction is dependent on the 
stereochemistry of the substrate. However, this theory has not been sustained by 
more recent research, where the ratio of products seems to be dependent upon the
nature of the acid used as catalyst^. In general, the conclusion is that weak acids, 
or low acid concentrations, promote cyclisation in favour of (12) whereas stronger 
or higher acid concentrations promote cyclisation in favour of a 
tetrahydrocarbazole (14)
The essential feature in the Fischer Indole synthesis is the direction of tautomerism 
as illustrated [Scheme (11)]. The difference in the yields of the above products 
then depend upon those factors, which favour one tautomer over the other. 
Normally protonation of the individual tautomers is deemed to be essential for
rapid cyclisation (paths B and C), but cyclisation without protonation (paths A and 

























Sainsbury and co-workers have also noted that the nature of the acid and the 
addition of sodium acetate dictate which of the indole (14) or the indolenine (12) 
are favoured in the indolisation of 1-decalone with 4-isopropylphenylhydrazine.
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From MM2 calculations, it appears that the indole (14) is favoured over the 
indolenine (12) (but only by about 10 kcal.mol'1). These data were obtained with 
the PC Spartan programme.
Sainsbury et al. found that using 4-sulfosalicylic acid in glacial acetic acid at 110°C 
favours the formation of the indole (14) over the indolenine (12) (5:1). However, 
when toluene 4-sulfonic acid was used in toluene at 100°C a ratio of 1:1 
(indole: indolenine) was observed. The addition of sodium acetate to the reaction 
mixture was found to enhance the formation of the corresponding indolenine (12) 
rather than the expected indole (14). In particular, when 10% sodium acetate in 
acetic acid was used, compound (12) outweighed (14) by a ratio of 5:1. This bias 
was increased slightly when 4-isopropylphenylhydrazine hydrochloride was used 
instead of 4-isopropylphenylhydrazine.
The effect of sodium acetate is assumed by us to extend beyond that of simply 
acting as a buffer and acts to modify in someway, the energy content of at least one 
intermediate in the reaction process. In the absence of acetate ion, (14) dominates 
as a result of the natural preference of the less sterically constrained (£)-hydrazone 
(15), thus leading directly to the less substituted ene-hydrazine (16) by prototropic 
rearrangement. However, in the presence of sodium acetate the indolenine (12) is 
preferred as now the acetate may combine with either the (E) or (Z) hydrazone to 
form a common tetrahedral intermediate (17). This could lose acetate ion 
returning either hydrazone, but eliminates acetic acid to favour the more 
substituted ene-hydrazine (18), resulting in indolenine formation, [Scheme (12)].




















In the authors hands the earlier work at Bath was repeated successfully and a good 
supply of the indolenine was built up, despite the need to separate it from the 
isomeric indole by column chromatography.
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We were now in a position to consider some new work. It is well known that 
indoles and other nitrogen heterocycles upon JV-acylation or TV-sulfonation can be 
deprotonated by the action of alkyllithiums at sites proximate to the ^-activating
group26-31 Once deprotonated the anion is stabilised in the form of a chelated 
complex [Scheme (13)].





Normally, the 2-position of indoles is the site of complexation and subsequent 
attack by added electrophiles occurs at this position. However, should our 
indolenine (12) be activated in this way we speculate that either C-7 or C-9 might 
be involved.
In an initial attempt to investigate these possibilities we reacted (12) with di-tert- 











After 4-5 weeks we noted the formation of the desired N-tert-butoxy derivative 
(20), but only in 36 % yield. The !H NMR spectrum of the product exhibits a 
double doublet at S5.9ppm, which corresponds to the resonance of the olefinic 
proton at position C-7. The extremely slow reaction rate must surely reflect the 
steric congestion around the indolenine nitrogen atom and/or the reluctance of the 
system to tautomerise.
Next the N-tert-butoxy derivative (20) was redissolved in ultra dry THF and the 
solution cooled to -78°C. terf-Butyllithium was added slowly and, after stirring for 
90 min, a deep red coloration was observed. At first this was taken to mean the 
formation of the chelated carbanion, however, when the solution was quenched 
with methyl iodide the now colourless reaction mixture did not contain any new 
products. In similar reactions now using either allyl chloride or deuterium oxide as 
electrophiles no new products were either detected or isolated. Bearing in mind 
the constraining nature of the cyclohexane ring fusion in the indolenine and the 
comparative difficulty in obtaining this compound we now switched to the simpler 
model l,2,3,4-tetrahydro-8-isopropyl-9b-methylcarbazole (22). This was 
synthesised from a Fischer indolisation reaction between 2-methylcyclohexanone 
and 4-isopropylphenylhydrazine in essentially the same manner as needed for the 






Reacting (22) with di-ferf-butoxycarbonate and sodium acetate in THF afforded 
the desired N-acylamine (23) as the sole product in less than 3 days; considerably 








This boded well for the lithiation/substitution reaction. However, a lithiation 
attempt with ter/-butyllithium and subsequent addition of methyl iodide gave only 
starting material. Furthermore, an experiment in which deuterium oxide replaced 
methyl iodide as the electrophile also returned the A^-acylated tetraydrocarbazole 
(23). We can only assume that activation of carbazole analogues of the type 
cannot take place through six membered chelation, unlike indoles where this 
process involves a five membered cyclic array.
With this in mind we now reduced the tetrahydrocarbazole (22) with sodium 
borohydride to give hexahydroanalgoue (25). Here, there is a proton alpha to the 
indoline nitrogen atom. Once activated and lithiated this could fulfil the
requirement for a 5 membered lithium chelate. Katritzky and c o - w o r k e r s - ^  have 
used carbon dioxide as an activating agent in chemistry of this kind. For us it also 
has the major advantage of being substantially smaller than the Boc group. Hence,
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the author decided to repeat the reaction shown in [Scheme (17)] using the method 












First the hexahydrocarbazole (25) was treated with butyllithium, followed by 
carbon dioxide to form the carbamate (26). A lithiation step was next required 
using ter/-butyllithium and finally the addition of an electrophile to form the a - 
substituted hexahydrocarbazole (27).
In practice this reaction sequence seemed to work as planned, but after work up 
only the hexahydrocarbazole (25) was obtained in near quantitative recovery.
We were unsure of the reason for this failure and decided to move rapidly to
another approach, namely halogen-lithium exchanged 34 jn order to achieve 
this, we reacted the A-acylated tetrahydrocarbazole (25) with A-bromosuccinimide
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(NBS) in the presence of a catalytic amount of hydrogen peroxide anticipating that 












In reality however, a multi-component mixture of products was obtained. 
Separation of the mixture by column chromatography afforded one compound in 
an almost pure state. The identity of this adduct (30) was initially indicated by 
FAB spectrometry that revealed molecular ion peaks at m/z 425 
(^+1)7427(^+1) ie. a true molecular ion at 424/426 in a ratio of 1:1 typical of 
the isotopic abundance of a compound containing a single bromine atom. A major 
fragmentation peak occured at m/z 406/408 indicating the loss of 17 mass units. 
This together with the IR spectrum, which exhibited a broad band at Vmax 3160cm'1 
suggested that we had formed the carbinolamine (30) from the iminium 





Interestingly, the *H NMR spectrum of this compound shows the resonance of H-7 
as a dd (ortho and meta coupled) at 57.1 ppm and that of H-9 as a doublet (meta 
coupled) 57.2 ppm. However, the resonance of H-6 at 57.4ppm is a broad singlet. 
We considered that this lack of definition was due to the slow rotation of the amide 
bond, and when the contents of the NMR tube were warmed to 50°C, the H-6 
signal sharpened and now became an ortho spin-related doublet. At this 
temperature a broad signal previously unnoticed was also apparent at 56.9ppm. 
This resonance may be due to the carbinolamine hydroxy proton, which was 
unaccounted for at ambient temperatures. However, a deuterium exchange 
experiment at ambient temperature was not entirely unambiguous, simply because 
the original signal was very broad. In addition, there are other resonances in the 
same vicinity, which render intergral changes, before and after, deuteriation 
difficult to measure.
The rest of the *H NMR spectrum remained unaffected by heating and shows H-4 
to resonate as an apparent triplet at 54.2ppm. The coupling constants to 3Ha and 
3Hp are the same (J= 4.8Hz).
Had this compound been formed in higher yield we might have continued work 
with it, but since it was not we progressed by attempting to functionalise the parent 
carbazole at C-9.
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A report by Iwao et that indicates that 7-substituted indolines can be 
successfully prepared via directed lithiation of 1-tert-butoxycarbonylindolines in 





This report stimulated us to attempt this methodology with our substrate; the 









However, treatment of the A-acylated tetrahydrocarbazole (23) with sec- 
butyllithium in the presence of TMEDA in THF at -78°C for 1 h, followed by 
quenching with methyl iodide proved totally unrewarding and no substituted 
product was detected.
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There is clearly an unresolved problem in these deprotonation attempts; but with 
little evidence to provide the basis of new experiments, we decided to attempt a 
direct bromination of the tetrahydrocarbazole (23), reacting it with NBS in the 







After 16 h, TLC analysis of the reaction mixture revealed a new compound which 
was isolated in a 29% yield. This proved to be the monobromo compound (33), 
where attack upon the aromatic ring had occurred as indicated by the NMR 
spectrum. In this spectrum two doublets were observed; one at 67.1 ppm and 
the other at 67.3ppm. These doublets are spin-related with J=1.5Hz, characteristic 
of the signals of two meta protons on a benzene unit. This contrasts with the 
clearly defined AMX pattern of the parent compound (22) at 67.2ppm (d ./meta 
=1.8Hz)) , 67.2 (dd yortho=7.9Hz Jmeta=1.8Hz) and 67.5 (d Jortho=7.9Hz). Clearly 
this compound is the C-6 bromo derivative (33).
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An attempt to try and increase the yield of (33) by replacing NBS with bromine in 
the presence of aluminium tribromide was unsuccessful. TLC analysis of the 
reaction mixture showed the presence of many compounds, but column 
chromatography was unrewarding. However, mass spectrometry of one 
component, still crude, showed the presence of molecular ion peaks m/z at (461), 
(463), (465) and (467) in the ratio of 1:3:3:1, typical of the isotopic abundance of 
3 bromine atoms.
Not withstanding the low yield of the bromo compound (33) using NBS, we 
continued to use it in a direct halogen-metal exchange reaction. Treatment with 
butyllithium in THF and TMEDA at -78°C under nitrogen, followed by a period at 
-20°C and then recooling to -78°C, gave a deep yellow solution. Methyl iodide #
was added and the solution was then allowed to warm to room temperature. Upon 
work up, however, the debrominated tetrahydrocarbazole (22) was obtained. 
There was no sign of other products, although clearly the intermediate lithiated 
compound must have formed. The procedure was repeated several times, since we 
were concerned that water had been inadvertently introduced before the methyl 
iodide. In each case the result was the same hydrodebromination product. Our 
conclusion was that methyl iodide is just insufficiently reactive towards the lithiated 
intermediate, hard though this is to explain.
Turning to the literature, we noted that Keck^G, 37 had successfully allylated 





With this in mind we decided to adopt the method used by Keck with our 
brominated substrate. Addition of 0.15eq of AIBN, as radical initiator, to the 
reaction mixture every hour over a period of 5 days resulted however, only in the 
isolation of unreacted starting material. The failure of this reaction was not 
immediately forthcoming, although it may be a result of decomposition of radical 
species before reaction with allyltri-n-butyltin can take place.
The palladium-catalyzed coupling of haloarenes with alkenes was first introduced 
by Heck in 196838-40 ancj has subsequently found use in a large variety of 


















Where the mechanism is as follows:
RX + Pd [~RPdx] (a)
[jRPdX~]
H H R
R /  \P d X [~H Pdx] (b)
[jfiPdx] + R3'N Pd + R 'N H +X- (c)
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The key step (b) is the palladation of the alkene component by a complex 
[R1Pd(PPh3)2X] formed initially from the aryl halide R*X and Pd°. It should be 
noted that this process is catalytic in terms of the palladated reagent. A range of 
halogen (and other groups X) have been used. A weak base such as triethylamine 
is normally present ostensively to remove the HX generated.
Reaction of the bromo compound (33) with methyl acrylate in the presence of 
palladium acetate, triphenylphosphine and triethylamine [Scheme (24)] afforded 
successfully the alkenylated tetrahydrocarbazole (35) in 41 % yield.









In many ways we were surprised that the reaction had worked. For example, the 
palladation of the bromocarbazole does generate a large structural array, which 
from our earlier results might have seemed unlikely to react. However, the 
synthesis of compound (35) prompted us to use the same methodology to prepare 












Of course the bromo compound had to be synthesised first and when the indolenine 
(12) was treated with NBS in the presence of a catalytic amount of hydrogen 
peroxide, at least two new compounds were generated. Unfortunately, these 
compounds possessed similar retention indices on silica gel, but we were able, # 
nevertheless, to isolate from the mixture the more polar component in the pure 
state, albeit in low yield 15 %. The identity of the isolated compound was 




In the ^-N M R spectrum of this compound two doublets at 87.4 and 7.5 with a 
coupling constant J=1.5Hz were observed. The chemical shifts and coupling 
constants are indicative of a meta relationship of protons on the benzene ring. 
Mass spectrometry reveals molecular ions at m/z 345 and 347, in the ratio of 1:1, 
consistent with the isotopic abundance for a single bromine atom.
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The !H-NMR spectrum of the less polar component of the mixture possesses 
several idiosyncrasies, the most likely suggestion is that it is a mixture of two 
dibrominated isomers (38) and (39). Mass spectrometry reveals molecular ions at 
425, 427 and 429 in the ratio of 1:2:1, consistent with two bromine atoms. While 
one bromine atom seems located at C-9 in both components ^-NM R evidence 
suggests that in one C-7 is the site of the other. For example there are two 
resonances at 65.4 and 4.4 pm that can be assigned to the alkenic and allylic proton 
resonances of compound (39). The signals of the other component are not 
assignable with any degree of confidence, but from a mechanistic point of view a 
reasonable conclusion is that this compound has to be the 7,9 dibromo isomer (38)
(39)(38)
Compound (38) is formed presumably by a reaction involving the enamine (36a), 
whereas (39) must be the result of a radically induced allylic bromination of the 
same substrate [Scheme (26)].
The initiation steps involve the generation of a low concentration of bromine from 
NBS in the presence of the initiator hydrogen peroxide.
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Coupling of the monobrominated compound with methyl acrylate under the same 
conditions as for tetrahydrobromocarbazole (33) afforded the desired allyl 
derivative (37) in 41 % yield.
Having obtained the ester (37) the next step was to hydrolyse the ester so to 







It was our intention that either the ester or the acid might be used to anchor 
various lipophilic units, but although the synthesis of the acid was accomplished by 
the action of aqueous sodium hydroxide at reflux, further work would have 
necessitated the preparation of more starting material. At this point we felt other 
areas might be more rewarding. For example, while the above work was in 
progress we anticipated using a Claisen rearrangement of the N- 
allyltetrahydrocarbazole (42) to afford the 6-allyl isomer (43) [Scheme (29)]. 
Once isolated, ozonolysis of this product would give the aldehyde (44). This, or a 


















Little work has been reported in the literature on the Claisen rearrangement of N-
allylcarbazoles. Previous unpublished work at Bath^l shows that treatment of the 
jV-allylcarbazole (45) with aluminium trichloride in DCM affords three C- 









Clearly the second product is formed from the first by the addition of 
hydrochloride and the third is formed either intramolecularly through several 
rearrangements or an intermolecular process. In our case where there is only one 
aromatic nucleus a similar reaction should be more straight forward. With this in 
mind, we attempted to repeat such a reaction upon compound (42).
The iV-allyltetrahydrocarbazole (42) was prepared successfully by reacting the 
parent compound (41) with allyl bromide in the presence of sodium hydride. 
Treatment of (42) with aluminium trichloride in DCM at room temperature, 
however, afforded only starting material, even when left for 24 h. Repetition of the 
reaction under several sets of conditions (even under sonication) gave the same 
result and starting material was recovered quantitatively.
We note that Izumi et al.42 working with indoles have experienced similar results 
when using aluminium trichloride as a “catalyst”. In this case the problem was 
overcome however, by changing aluminium trichloride for zinc bromide. It is a 
distinct possibility that the aluminium salt binds strongly to the indole system.
Previous work at Bath^l for the carbazole example using zinc bromide however, 
failed to effect a rearrangement.
At this point the experimental work in this area was reassessed and no further 
effort to resolve this problem was undertaken. We had, of course, shown how to 
synthesise a similar product through the Heck procedure, but even here future 
work would be necessary to protect C-4a adjacent to the nitrogen atom. The 
immediate objective of any further work in this area would thus be to synthesise
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compounds of the type (49). The postulated route is shown in the following 





Obviously this represents a considerable amount of work and at the end the final 
products contain three chiral centres. From a pharmacological point of view this is 
undesirable and our thoughts turned to alternative targets where the problem of 
chirality is eliminated. It was this which promoted the idea of using a similar 
molecular template to that of the indolenine (12) and to synthesise achiral spiro 
compounds of the type (50), where the piperidino nitrogen atom could be used to 




Before we began work in this area however (Section 3.0), we needed to resolve 
some aspects of the chemistry of arylimines, which had presented themselves 
during this and earlier work. In particular, we had accumulated evidence to show 
that the addition of alkyllithiums to indolenines may not be a simple two-electron 
process.
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3.0 Single electron transfer as a mechanistic feature in the 
alkylation/addition reactions of indolenines
In the course of studying simpler analogues of the tetrahydrobenzocarbazoles (12), 
our co-workers in Sweden had shown that (51) was an effective chain breaking 
antioxidant, which binds selectively to low density lipoprotein (LDL) particles in 
plasma.
( 5 1 )
The mode of synthesis was to form the corresponding inline (52) by a Fischer 
indolisation reaction between 2,4-dimethylphenylhydrazine and phenyl isopropyl 
ketone, and then add cyclohexyl lithium. The last reagent was prepared by adding 
cyclohexyl chloride to terf-butyllithium. This reaction did not work well and the 
best yield of the antioxidant (51) never exceeds 50-60%. Other components in the 
reaction mixture seemed not to contain the cyclohexyl unit, but rather tert-butyl 
groups and the problem was handed over to the Bath group for resolution. 
Sainsbury’s group soon confirmed that the cyclohexyl group was not transferred to 
these side products, which were isolated and identified as (53), (54) and (55). 
Clearly these compounds resulted from the incomplete halogen-metal transfer 
reaction between te/7-butyllithium and cyclohexyl chloride, and it was discovered
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that treating the indolenine (52) with ferf-butyllithium alone gave rise to a mixture 
of (53), (54) and (55) plus other minor products all containing tert-butyl groups.
To account for the formation of these products it was postulated that the reactions 
could proceed in two distinct ways:
(1) Overall nucleophilic addition across the imine double bond to afford the 
corresponding alkylarylamine (53) as expected and
(2) Conjugative attack upon the aryl ring to form (54) and (55).
It is thought that both reactions (1) and (2) proceed by a common first step, which
involves SET between the alkyl lithium and the imine double bond^. This leads to 
a caged unit containing the alkyl radical, the radical anion of the imine and a 
lithium cation [Equation (1)]44, 45
Scheme (32)
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R—Li + ^ = N —X -------- ► [ R* + Li + \ — N —X ] ---------
R X
Equation (1)
In the case of imine (52), delocalisation of the radical anion must be a factor, 
allowing for the rationalisation for the formation of products (54) and (55) as 
shown.
Scheme (33)
It is well known that imines react conveniently with organolithiums and Grignard 
reagents yielding the halolithium or halomagnesium salts of the resultant addition
product: an amine^.




However, reliable details for such an important reaction are surprisingly scarce. 
Although the actual structure of Grignard reagents, is still a matter of dispute, 
extensive studies based upon X-ray crystallography and NMR measurement 
indicate that metallated alkanes are clearly defined aggregates. While the addition 
of such reagents to simple imines may be nucleophilic (2-electron) in nature, the 
reactions of diarylimines are much more likely to involve 1-electon transfer 
processes, although a distinction between two very rapid single electron transfers 
and a simultaneous 2-electron reaction is hard to make. For diarylamines we 
suggest that the second electron transfer is much slower than the first. Here, of 
course, the initially formed radical anion can gain some stability through resonance. 
This point will be reinforced later. Certainly there is circumstantial evidence in 
favour of this type of process since the phenomenon of “conjugative” addition to 
diarylamines has been known for many years.
Gilman and his c o - w o r k e r s ^ ,  for example, reported that the reaction of N-(2- 
methoxyphenylmethylene)aniline and phenylmagnesium bromide under “forcing”
conditions^ afforded a product, the structure of which suggests conjugated attack 


























One possible explanation of this result is that phenylmagnesium bromide acts as a 
source of phenyl radicals (probably within a solvent cage). These then attack the 
methoxylated aromatic ring at an (pso-position. Elimination of methoxide radical 
reforms the imine function to which a conventional nucleophilic addition occurs.
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More recent work^^ has confirmed Gilman’s work and has also shown that the
dimer (63) is formed. Again the last compound can be assumed to form by C-C 
coupling of the radical anion (57).
With this evidence it is now possible to rationalise what is occurring with the imine 
(52). We conclude that ferf-butyllithium reacts with the imine double bond to 
afford a caged unit containing the tert-butyl radical, the radical anion of the imine 
and a lithium cation as shown (see also equation 1).
'BuLi +  > = n -R jjBuLi* + lBu + y - K L ?
R
Resonance within the radical anion permits reactions at aryl ring sites and the tert- 
butyl radical then affords the products (54), and (55).
Further evidence for such a single-electron transfer process, comes from the early 
work of Smith and his colleagues. These workers have shown45, 50-54 that alkali 
metals, in an aprotic solvent, combine with imines and alkyl halides to give a- 
alkylamines. Originally Smith considered this process to involve the addition of 
two electrons (from the metal) to afford a dianion. This then reacted with the alkyl 
halide to displace halide [Scheme (36)].
R
—  + 2Na
R










Later he revised this opinion and suggested that a single-electron transfer 
mechanism might operate in certain cases.
This type of reaction suggested to us that a metal/alkyl halide reaction might prove 
more effective in adding a cyclohexyl unit to the indolenine (52). In fact we 
decided to use a range of alkyl and alkenyl halides and acetic anhydride in 




M = Group 1 Metal
RX= Alkyl Halide
Cyclohexyl (a) Isopropyl ( g)
Scheme (37)
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In the first series of reactions [Table (1.0)] sodium was used as the electron-donor. 
The yields of products, however, are very low:
In addition to the required product we also obtained the conjugative adducts (65) 
in some cases.
Conditions Expt no Alkyl halide Isolated yield of 
product(s)
-78°C, 4 eq Na, 4hr 1 Cyclohexyl chloride (64a), 2%, (65a) 
<1%
-78°C, 4 eq Na, 4hr 2 Benzyl bromide (64b) 2%
-78°C, 4 eq Na, 4hr 3 Allyl bromide (64c) 2%
-78°C, 4 eq Na, 4hr 4 Acetic anhydride (64d) 2%
RT, 4eq Na, 4hr 5 Isopropyl iodide (64g) 2%, (65g) < 
1%
RT, 4eq Na, 4hr 6 Trityl chloride (64h) 0%
RT, 4eq Na, 4hr 7 yy-Dimethylallyl bromide (64f) 1%
RT, 4eq Na, 5hr 8 Benzyl bromide (64b) 10%
Table (1)
Following the procedure of Smith and co-workers, the imine (52) was treated with 
four equivalents of sodium metal as the radical anion generator. After 4 h at room 
temperature, the black solution was siphoned off from the excess metal. The 
solution was then cooled to -78°C, before the addition of the halide (experiments
(1-4)).
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TLC analysis of the reaction mixture normally revealed the presence of three 
compounds. The major component in each case proved to be starting material. 
For most reactions another component was the a-alkylated amine (64i) or an 
analogue, and the minor component corresponded to the formation of the 
conjugative addition compound (64). Indeed trityl chloride failed to react, 
presumably for steric reasons, and only benzyl bromide gave a reasonable yield 
(10%) of the a-benzylated adduct (64b).
Such low yields caused us to vary the metal used and the temperature of the 
reaction, a summary of some of our results is given [Table (2)].
Conditions Expt no Alkyl halide . Isolated yield of 
product(s)
-78°C, 4eq K, 4hr 13 Benzyl bromide (64b) < 0.5%
RT, 4eq K, 4hr 14 Benzyl bromide (64b) 0%
-78°C, 4eq Li, 4hr 15 Benzyl bromide (64b) 1%
RT, 4eq Li, 4hr 16 Benzyl bromide (64b) 0%
40°C, Xs Na, 5hr 17 Cyclohexyl chloride (64a) 0%
Reflux, Xs Na, 3hr 18 Cyclohexyl chloride (64a) > 1%
Reflux, Xs Na, 4hr 19 Cyclohexyl chloride (64a) 0%
Table (2)
With potassium metal for example 0.5% of the a-benzylated amine (64b) was 
formed at -78°C, but none at room temperature.
With lithium the same benzyl bromide afforded 1% of the same product at -78°C, 
but none was isolated at room temperature. Changing the alkyl halide to 
cyclohexyl chloride and the use of sodium at various temperatures (reflux down to 
-78°C) (experiments 1, 7-9) and reaction times gave a maximum 2% yield of the a- 
cyclohexyl compound (64a) (at -78°C). Although the isolated yields of the adducts 
were all very low, there did seem to be a general reduction in productivity upon 
raising the temperature above room temperature. Perhaps this can be attributed to 
the thermal instability of the radical anion or radicals, but the information we have 
to support this statement is limited.
Interestingly, modest increases in yields were observed when AIBN was added to 
sodium mediated reactions (in the presence of light), between the imine and •
cyclohexyl chloride, benzyl bromide and allyl bromide at -78°C. However, when 
benzyl bromide was used at room temperature the addition of the initiator caused 
the yield of the a-alkylated adduct to fall from 10% to 5%. If sodium is omitted 
from the last reaction and AIBN is activated only by light (sunlight or ultraviolet 
light) no products were isolated.
Conditions Expt no Alkyl halide Isolated yield of 
product(s)
-78°C, 4eq Na, 4hr, AIBN 9 Cyclohexyl chloride (64a) 2.7%
-78°C, 4eqNa,4hr, AIBN 10 Benzyl bromide (64b) 4.1%
-78°C, 4eqNa,4hr, AIBN 11 Allyl bromide (64c) 4.3%
RT, 4eqNa,4hr, AIBN 12 Benzyl bromide (64b) 5%
Ta )le (3)
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At this point we decided to examine another imine (66), from 2-bromoaniline and 
2-methylbenzaIdehyde in order to see if an intramolecular cyclisation might occur. 
One could envisage an intramolecular cyclisation proceeding more readily than an 
intermolecular one. The anticipated reaction is shown in [Scheme (38)], and 
should the radical anion react at the C-Br centre, then the dihydrophenanthridine 








In practice however, all attempts at inducing the reaction with lithium or sodium 
failed. No tangible products could be isolated or detected and complex mixtures 
were formed. The components of these mixtures proved intractable when 
subjected to column chromatography.
Due to this apparent lack of control in such reactions it was decided that 
electrochemistry might be a way forward, since this technique should allow much 
greater regulation of reduction potential and thereby limit side reactions.
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3.1 Electrochemistry of imines: an introduction
Electroorganic chemistry provides a convenient and clean method for the 
generation on a preparative scale of many reactive intermediates. In 
electrochemistry electrons are regarded as the reagent and the electrode potential 
thus controls the availability of the reagent. The molecules are activated by the 
addition or removal of electrons at an electrode. This must involve addition to a 
LUMO (reduction) or removal from a HOMO (oxidation).
The most important, intermediates formed electrochemically are radical ions, 
radicals, carbocations, and carbanions. The reactivity of the electrogenerated 
species is as expected; radical-anions maybe nucleophilic or basic, radical cations • 
are electrophilic, and both may react as radicals to undergo coupling. In this part 
of the project we hoped to bring about such a coupling reaction between the 
radical anion of an arylimine and the radical formed from the an alkyl halide. First 
however, it is necessary to describe some fundamental terms and procedures used 
to describe and monitor electrochemical processes.
Mass Transport
A consideration of modes of transport to, and from the electrode surface within an 
electrolyte is of practical importance to the electrochemist. Three forms of 




Difiusion occurs when localised concentration gradients exist. Entropic forces act 
to smooth out these uneven distributions of concentration and are therefore the 
main driving force for this process; normally the larger the gradient the greater the 
rate of diffusion. Consider a substrate (O) which is oxidised at the electrode 
surface and forms a chemical product (R). In the region near the electrode where 
diffusion currents are established (0.003-0. lcm) the concentration of substrate (R) 
will be less then in the bulk phase and hence the substrate will diffuse towards the 
electrode surface. On the other hand the product (R) will diffuse away from the 
electrode into the bulk phase where its concentration is less.
Convection
Convection results from the action of a force on the solution. There are two forms 
of convection. The first is natural convection, which is present in any solution. 
This is generated by small thermal or density differences and it acts to mix the 
solution in a random and therefore unpredictable manner. It is possible to ‘drown 
out’ the natural convection effects from an electrochemical experiment by 
deliberately introducing convection into the cell. This second form of convection 
is known as forced convection.
Migration
Migration is essentially an electrostatic effect, which arises as a result of applying a 
voltage across the electrodes. This effectively creates a charged interface. 
Because of this migratory effect most voltammetric measurements are performed 
upon solutions, containing an excess of a background electrolyte (e.g. KC1) that 
does not undergo electrolysis itself, but acts to shield the reactants from such as 
effect. It should be noted that the purpose of introducing a background electrolyte
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into a solution is not however solely to remove migration effects as it also acts as a 
conductor to lower the internal resistance of the cell.
Experimental Cell
For the majority of electrochemical syntheses, a suitably designed cell is
mandatory, but for some, a simple one compartment cell is adequate^. The most 
basic arrangement has both electrodes (the anode and the cathode) immersed in a 
conducting solution (the electrolyte), which is usually a combination of a solvent 
and a supporting electrolyte. On applying a potential difference between the 
electrodes a current flows and electrolysis occurs. This current flow through the 
system involves firstly, electronic conduction through the external elements of the 
circuit, followed by ionic conduction. This involves the movement of dissociated • 
ions in solution under the influence of an electrostatic field. Finally, electron 
transfer occurs either to or from the electrode to the species (M) at the cathode or 
anode. Clearly, in a one component cell there is the possibility of both cathodic 
reduction and anodic oxidation of the substrate. To overcome this problem a two
compartment cell may be used, in which the sections are divided by a glass frit^ .
This frit is porous enough for ionic conduction, but it is assumed to be 
insufficiently permeable for diffusion of the substrate.
It is usual to conduct voltammetric experiments using a three electrode system in 
which a counter electrode (CE) is associated with a working electrode (WE) and a 
reference electrode (RE). The last is used to monitor the potential of the WE. The 
usual arrangement is to ensure that current only flows between the WE and the 
CE. The potential of the WE is often held at a constant value relative to the RE.
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Considerations of the electrode ‘layout’ within the cell must also be noted as yields 
of products may be affected by poor positioning. For the minimum electrical 
resistance in the cell the distance between the anode and cathode should be as 
small as possible
Practical requirements
The essential elements needed for a preparative electrolysis are as follows:
(i) The electrodes:
The nature of the CE is not critical, providing it is chemically inert under the
experimental conditions, a mercury pool or a platinum g a u z e ^ 5  are commonly 
employed. The restrictions imposed upon the working electrodes are far greater. .
For example in oxidation this limitation is caused by the fact that most metals are 
themselves oxidised at fairly low electrode potentials. Platinum (and the platinum 
group metals), however, exhibit good characteristics in this respect and hence 
maybe used in electro-organic reactions at fairly high electrode potentials, other
electrodes such as carbon and lead d i o x i d e ^ ,  56 have also been commonly used.
For reductions a mercury pool cathode is commonly u s e d ^ 5 ,  5 6
(ii) The solvent:
Due to the insolubility of most organic compounds in aqueous media, organic 
solvents normally form the basis of the electrolyte system. Therefore the ideal 
electrolyte system must fulfil several requirements.
• It must be electrochemically inert in the potential range of the experiment.
• It must be a good solvent for organic substrates.
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• It must be unreactive towards the intermediates present in an electrochemical 
process.
• It must have a fairly high dielectric constant.
• It must be comparatively easily purified and dried.
Most of these criteria are self explanatory, but the need for a solvent with high 
dielectric constant is necessary to minimise the electrical resistance of the 
electrolyte as well as increasing its solubility. Needless to say there are few
solvents that fulfil all of these demands, but acetonitrile and DMF^? are most 
commonly employed.
(iii) Background electrolyte and the electrolyte (reactant):
The restrictions placed on the supporting electrolyte are similar to those for the .  
solvent, but additionally solubility in the solvent is, of course, an important factor.
The most common electrolytes are alkali metal perchlorates^ and tetra-n-alkyl 
ammonium fluoroborates or p h o s p h a t e s ^ .  These background electrolytes are 
usually added in high concentration 0.1M to allow a reasonable passage of current 




Voltammetry is one of the techniques that electrochemists employ to investigate 
electrolysis mechanisms. There are numerous forms of voltammetry, but here we 
will consider only cyclic voltammetry. For each case, a voltage or series of
66
voltages are applied to the electrode and the corresponding current that flows is 
monitored.
Cyclic Voltammetry
Cyclic voltammetry is a technique that allows one to scan the potential of the 
working electrode in the anodic (or cathodic) direction and observe peaks due to 
oxidation (or reduction) of a substrate. The potential can then be scanned in the 
opposite direction and peaks due to reduction (or oxidation) of intermediates 
formed during the forward scan may be observed. Ordinarily, an isosceles 
triangular waveform is used and the potential of the working electrode is varied 
linearly with time, beginning at point a and continuing to point b (switching 
potential) from which the potential is decreased linearly with time to generate the 





The current at the peak potential is given by the Randles Sevick [Equation (2)]:
Equation (2)
ip = Peak current/amps
A = Electrode area/cm
v = Rate of potential change/vs'1 
k = Randles Sevick constant 
D = Diffusion coefficient of the 
electroactive substance/ cmV1 
n = No of electrons transferred in 
electrode reaction 
Cbuik -  Bulk concentration of 
electroactive substance/mol cm'3
A cyclic voltammogram for a reversible (fast charge transfer) reaction is shown
[Figure (11)] :






The starting point a is selected such that no current flows when the cell circuit is 
closed. From point a the voltage is scanned in the cathodic direction; as point b is 
reached, reduction of R begins and the current increases with increasing electrode 
potential until point c is reached, where depletion of substrate at the electrode 
brings about a decrease in current and the observation of a peak.
The direction of the voltage sweep can be changed at point d and a peak is 
observed at e on the anodic sweep which corresponds to the oxidation of R. Since 
there are no coupled chemical reactions, no other anodic peaks are observed and 
the second cycle differs from the first only slightly due to changes in concentrations 
of R and O at the electrode.
A cyclic voltammogram for the quasi irreversible (slow charge transfer) reaction is 
illustrated [Figure (12)]:






The form of this voltammogram is identical to the first with the exception that both 
the peak width and the peak separation are much greater than that observed for the 
reversible case. The deviation here is a consequence of the fact that a slow charge 
transfer takes place. Thus the deviation from the reversible voltammogram 
becomes greater as the voltage sweep rate is increased.
The third general case, reversible reduction of O  + ne -» R  with a coupled 
chemical reaction (eg EC mechanism), demonstrates the most useful aspect of 
cyclic voltammetry in the study of organic electrode processes [Figure (13)]:
The [Figure (13)] below shows a cyclic voltammogram for an EC reaction, in this 
case the electron transfer reaction is reversible and the chemical rate constant Kec 
is extremely large.
E O + e — R
/6Gc








A notable fact is the reverse peak is reduced in comparison with the forward one. 
This is because the initial electrolysis product (R) is removed by the fast follow up 
chemical reaction. Thus, when the voltage is swept back there is little conversion 
into (O). Obviously if such a cyclic voltammogram is obtained a clearly defined 
product forming reaction is occurring. Furthermore, as the curves are 
uncomplicated the product is not itself reduced or oxidised within the range of 
voltages selected. Had this been the case other reduction and oxidation peaks 
would be superimposed upon the original trace during the second and subsequent 
cycles.
It should be noted that the size of the back peak can be explained in terms of the 
amount of material that reacts during the scan. For very small values of K E c  ( R )  is 
essentially unreactive on the timescale of the voltammetric measurement and so no 
difference is observed between this and the stable reversible electron transfer 
reaction. As K E c  increases, the size of the back peak begins to decrease due to the 
removal of ( R )  by chemical reaction.
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3.2 Electrochemistry of imines: Results
Nucleophilic attack upon imines can be achieved using many chemical reagents. 
However, cathodic reduction in the presence of an alkyl halide, which can be 
reduced to an alkyl radical in the same cell, offers an attractive alternative. Here a 
wide degree of selectivity should be possible through precise control of electrode 
potential.
In 1978 Degrand and co-workers 58, 59 reported that pyrrolidine and piperidine 
derivatives could be synthesised successfully by electrochemical reduction of Schiff 
bases in the presence of l,o-dibromoalkanes. In particular, the electrochemical 
reduction of N-benzalaniline (68) in the presence of 1,4 dibromobutane afforded 
1,2-diphenylpiperidine (69) as shown in [Scheme (39)].



































It has already been reported by Saveant and c o - w o r k e r s ^ O  that the JV-alkylation of 
the radical anion (70) competes with its protonation by residual water in the 
solvent. The formation, then the reduction of radical (71) into a cyclic compound 
is therefore favoured by an increase in the dibromobutane formation.
Degrand seems not to have taken this work further and we believed that we could 
validate our entry into this.
With this in mind, it was considered necessary for the author to employ the method
used by Degrand et al.5% to mimic some of the work already attempted in section 
(3.0). Initially, it would be necessary to prove that our equipment and 
experimental conditions were satisfactory; thus it was necessary for the author to 
repeat Degrand’s experiment with W-benzalaniline (68) and 1,4-dibromobutane. In 
her paper Degrand gave little information was given about the type of cell array 
used, so our initial set-up employed a typical 2 electrode, 2 compartment synthetic 
H-type cell [Figure (14)].
Figure (14)
A flat platinum gauze served as the cathode, previously cleaned in warm 
concentrated nitric acid. A silver anode was used and the electrolysis was run in 
DMF with tetrabutylammonium hexafluorophosphate (TBAHFP) as the supporting 
electrolyte. A ten fold excess of the alkyl halide was added since it had already
been noted^ that a large excess of 1,4-dibromobutane was necessary for an 
optimal yield of the piperidine (69).
During the course of our experiment a number of problems were encountered (i) 
The reduction potential of the TV-benzalaniline (68) (-2.0V) was found to be similar 
to that at which DMF was reduced, (ii) Platinum gauze has a high resistance, hence 
this gives rise to a potential drop across the electrode and an overall lack of 
potential control. These difficulties caused us to abandon the experiment. To 
circumvent these problems it was necessary to change the experimental set-up so 
as to define the applied potential more precisely. One idea was to use a system
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involving a three electrode arrangement. Indeed, this new set-up gave us an 
increase in control of electrode potential, and it was possible to run small cyclic 
voltammograms throughout the course of the experiment. However, we 
encountered problems in removing the product obtained from the electrode surface 
and into the bulk solution. To overcome this difficulty, we decided to move a more 
highly agitated system in the hope that any product made at the electrode would be 
rapidly transferred into the bulk solution and, in turn, facilitate the movement of 
substrate to the electrode surface.
The final cell design used a hydrodynamic set-up, where a rotating disc serves as 
the working electrode [Figure (15)]. The advantage of this is that one can change 




The rotating disc electrode consisted of a small platinum disc, which was 
embedded centrally within a large cylinder composed of Teflon (an insulating 
material). The cylinder was placed in a vessel that contained the reaction mixture 
and rotated at constant speed. In practice the rotation spins the solution out from 
the cylinder surface in a radial direction and this movement in turn, draws fresh 
material in towards the disc.
Before commencing with the experiment, cyclic voltammograms were obtained for 
TV-benzalaniline (68) and 1,4-dibromobutane. The cyclic voltammogram of N- 
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Figure (16)
The shape of this voltammogram is characteristic of a reversible system, as 
indicated by the almost equal peak heights for the forward and backward scans. It 
is also possible to deduce that the peak at -2.2V corresponds to a one electron 
reduction since the peak separation between reduction and oxidation is
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It is thus reasonable to conclude that the peak in the reductive sweep is due to the 
formation of an anion radical.
The cyclic voltammogram of 1,4-dibromobutane [Figure (17)] on the other hand 
shows the presence of two peaks at -1.2V and -1.8 V. This observation indicates 
that two reduction events are occurring, neither of which is reversible. We assume 
that first one bromine and then the other is lost as a bromide ion. Should this be 
the case, then there is a potential mismatch between that required for the reduction 













Nonetheless a preparative electrolysis was run in DMF as solvent, at a platinum 
rotating disc electrode, rotating at 40Hz with tetrabutylammonium 
hexafluorophosphate (TBAHFP) as supporting electrolyte. During the course of 
the reduction the solution turned a deep red colour and this encouraged us to think
that a radical process was occurring 51. After 8 h the catholyte was diluted with 
water, neutralised, extracted with diethyl ether and the solvent evaporated in 
vacuo. The desired product 1,2-diphenylpiperidine (69) (2%) was isolated, after 
purification by column chromatography.
Such a poor yield necessitated some investigation of, for example, the effect of 
solvent, but the use of acetonitrile or THF as replacements for DMF proved 
unrewarding. No significant improvements were seen when changing the 
background electrolyte from tetrabutylammonium hexafluorophosphate (TBAHFP) 
to sodium perchlorate, or to tetrabutylammonium perchlorate (TBAP). Changing 
the electrode from platinum to lead also proved fruitless, as after 20 min all the 
lead had decomposed. Using a mercury pool electrode gave rise to no tangible 
product. In view of these results we decided to stay with our hydrodynamic set-up 
as described above and address the main reason for our interest, namely the 





R = Cyclohexyl, Benzyl, Isopropyl 
X = Halide
R = H (Reduced compound)
Scheme (41)
Cyclic voltammograms were obtained for indolenine (52) and the respective alkyl 
halides prior to preparative electrochemical reductions. The cyclic voltammogram 
of the indolenine (52) shows a single, one-electron redox couple [Figure (18)]. 
The cathodic potential is approximately equal to -2.2V, which as we shall see is 
rather higher than that of some alkyl halides.
Current/mA
0.001










The reduction potentials of the alkyl halides we selected for a preliminary 
investigation are shown [Table (4)].
Alkyl halide EP°7V Ep " d/V
Cyclohexyl chloride -0.5 -1.1
Benzyl bromide -1.5 -1.7
Isopropyl iodide -1.9 -2.25
Table (4)
Hence the application of a voltage of -1.1V, -1.7V and -2.25V, respectively, to 
each of these halides should give rise to cyclohexyl, benzyl and isopropyl radicals. 
A potential of -2.2V would afford the radical anion of the indolenine.
Interestingly, it should be noted that when the indolenine (52) and an alkyl halide 
(for example isopropyl iodide in the case below) were mixed and the cyclic 
voltammogram of the mixture was run [Figure (19)], evidence for chemical 
products is gleaned from the redox couples at +0.9V and +1.2V. The nature of 
the products responsible for the new peaks could be the required c^-propyl 
indoline (R= ‘Pr). Indeed, if the potential of the cathode is maintained at -2.2V for 
about a minute the peak intensities at +1.0V and +1.4V increase in size, indicating 
that a chemical reaction is occurring, after initial reduction of the imine has taken 
place.
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Despite the fact that the indolenine and cyclohexyl chloride undergo reduction at 
widely different cathodic potentials, we conducted our first preparative experiment 
with these compounds. We knew that a potential of a least -2.2V would be 
required to reduce both species. Applying this potential and rotating the electrode 
at (40Hz) for 8 h resulted in the solution becoming a deep red colour. On work 
up, the catholyte afforded a brown viscous oil, which was separated into its 
components by column chromatography. From this oil, the starting material and 
the indoline (64, R=H) were obtained, suggesting, as anticipated, that the 
cyclohexyl chloride forms the cyclohexyl radical. The alkyl radical then combines 
with another radical before it has time to combine with the indolenine (52). 
Unaffected by the first reductive step, the indolenine (52) then undergoes reduction 
to the indoline (64, R=H) at its normal higher potential.
Because cyclohexyl chloride reduces much earlier than the indolenine (52) it was 
reasonable to change the alkyl halide. Benzyl bromide with a reduction potential 
closer to that of the indolenine (52) was selected for the next reaction. This was 
carried out in an identical manner to that described above. At the end of the 
electroreduction, TLC analysis indicated the presence of the indoline (64, R=H), 
and unchanged indolenine (52).
In view of this, benzyl bromide was replaced by isopropyl iodide as it is reduced at 
a potential even closer to that of the indoleine (52). However, once again no a- 
alkylated indoline was obtained.
Because of the positive outcome achieved from the initial experiment using N- 
benzalaniline (68) and 1,4-dibromobutane, we decided to replicate the reaction. 
This time indolenine (52) was selected as the imine and we envisaged that the 
expected product might be (76) [Scheme (42)].
+ Br(CH2>4Br
e
( 5 2 )
( 7 6 )
Scheme (42)
The electrolysis was run in DMF, at a platinum rotating disc electrode, rotating at 
40Hz with tetrabutylammonium hexafluorophosphate (TBAHFP) as supporting 
electrolyte. The cathode potential was set at -2.2V and left at this potential until 
the current had fell to almost zero. Once again the solution turned a deep red
colour. After subsequent work up the oily residue was subjected to column 
chromatography, however, only a trace of a new product (76) was obtained. This 
material was still impure and the amount avaliable made column chromatography 
impractial. Nonetheless mass spectrometry showed a molecular ion peak at m/z 
305 which is commensurate with that expected for the indoline (76). 
Unfortunately, due to the impuritites NMR spectra proved inconclusive. It 
should be noted that this experiment was repeated several times, varying the length 
of the electroreduction and the current density. Sadly no better result was obtained.
Due to lack of success in these experiments, it was thought that the reduction 
might be carried out in a similar manner to that of the chemical one i.e. formation 
of the inline radical anion first, before the addition of the alkyl halide. Thus, 
indolenine (52) was reduced at -2.5V for 4 h, then the alkyl halide was added. 
Once the alkyl halide has been introduced the mixture was then left stirring in the
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absence of any applied potential for a further hour. As expected, no products from 
an interaction of the indolenine and the dihalide were formed. Next the indolenine 
was reduced at -2.5 V for 2.5 h, before addition of the alkyl halide. This time 
electrolysis was continued for a further 8 h after the dibromide had been 
introduced. Again no positive result in terms of a-alkylated indoline product was 
observed and only the indoline (64, R=H) was identified in the reaction product.
It should be noted that the experiments were also repeated using a sodium salt as 
the background electrolyte, in an attempt to make the experimental conditions as 
similar to the chemical reduction as possible. No improvement was noted.
The failure of the indolenine (52) to undergo coupling with an alkyl halide was 
somewhat puzzling as products had been isolated previously albeit in low yield 
using the chemical approach. At this point we wondered whether the failure to 
effect such a reaction could be due to some inherent factor associated with the 
chemical reaction. One possible explanation is that in the chemical experiment, the 
alkali metal may provide a surface that can help to stabilise the reactive 
intermediates produced, as well as bringing the two reactive species closer for 
coupling.
Undeterred by negative results we decided to investigate one final reaction on 
another substrate where possible coupling would be intramolecular as opposed to 








If reduction of the imine to the radical anion (78) could be induced to occur before
reduction of the C-Br bond then we might anticipate the formation of the 
pyrrolidinyl radical. This should undergo rapid reduction to the anion and 
eventually give 2- phenylpyrrolidine (79) on work up. Other possible products 
might include the dimer (80).
From the cyclic voltammetry of the indolenine (52) a reversible couple was 
observed where EpOX = -2.0V and Ep1^  = -2.2V. The reaction was repeated several 
times using a similar setup to that employed previously. In a preparative 
electrolysis attempt a deep red colour was produced as soon as current passed 
through the cell. Once the cell current fell to virtually zero the catholyte was 
worked up, but it was clear from thin layer chromatography, that a multi 




components were obtained in sufficient amounts, or sufficiently pure, for 
characterisation. At this point it was decided that a chemical synthesis of some 
achiral antioxidants would be more rewarding and further work in the 
electrochemical area was not progressed.
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4.0 Piperidinotetrahydroquinolines
The first achiral targets considered were the piperidinotetrahydroquinolines .
R =C H 3 (a)
R = (C H 2) 5C H 3 (b)
R = (C H 2) 10C H 3 (c) 
R =(C H 2)7C H C H (C H 2)7C H 3 (d ) 
R =C H 2C (C H 3)2CH2C 0 2H  (e )  
R = (C H 2)6C H 2(C H C H C H 2)3C H 3 (f)  
R =C H 2PhC H 2C H C O N H C O S (g )
In these compounds the 4-methoxytetrahydroquinoline unit is assumed to be the 
locus of oxidation and the acid residue (RCO-), which is infinitely variable, could 
be used to fine tune the lipophilicity and selectivity of the antioxidant. Non- 
chirality is ensured by the spirocyclic nature of the sp3 carbon atom a- to the 
quinoline nitrogen atom.
It should be noted that the benzylic gem dimethyl groups are necessary to ensure 
that the ensuing radical cation, or radical, is not quenched by attack at this site by a 
nucleophile or a radical, respectively.
The piperidino compounds were chosen specifically to allow us to investigate 
structure/activity relationships, especially as the nature of the TV-acyl side chain 




In order to advance these objectives it was necessary to synthesise a good supply 
of 6-methoxy-4,4,8-trimethylspiro[piperidine-4,2-(l,2,3,4-tetrahydroquinoline)] 



















Condensation of the commercially available N-Boc protected piperidone (82) with 
4-methoxy-2-methylaniline (81) was achieved using standard Dean-Stark 
conditions (in toluene). The resultant inline (83) was obtained in 95% yield and 
was pure enough to be used directly in the subsequent step.
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The next step (a) proved more challenging. A one pot reaction between the imine 
(83), lithium sand, and 3-chloro-2-methylprop-2-ene in pentane afforded the 
desired compound (85), but only in 31 % total yield.
As the low yield might be a result of incomplete formation of the required 2- 
methylallyllithium reagent, we decided that we should prepare it independently in a 
separate step. Its purity could then be checked before addition to the imine. For 
this we planned to react a known amount with benzaldehyde in the anticipation of 
forming either the secondary alcohol (87) or its dehydration product (88).
The lithium alkenyl was prepared by treating 3-bromo-2-methylprop-2-ene in 
diethyl ether with lithium sand over a protracted period 30 h. When this was done 
and the solution quenched with benzaldehyde the alcohol (87) was formed in 
quantitative yield. Now when the reagent was prepared again and added to the 
imine no reaction occurred. Clearly the problem is here not with the reagent, but 
rather with the lack of reactivity with the imine.
It is well known that the addition of organometallic reagents to imines is often 
accompanied by competitive enolization/reduction and/or bimolecular coupling 
reactions due to relatively poor electrophilicity of the imine carbon and the 




aldehydes and ketones undergo exclusive enolization on treatment with alkyl 
Grignards.
To circumvent these problems, a number of methods have been d e v e l o p e d 6 7 - 7 6  
The strategy most commonly employed has involved activation of the imine carbon
to nucleophilic attack by co-ordination of a Lewis acid to the nitrogen lone pair^S, 
70,71
With this in mind we wondered if the low yield of the product (85), is due to 
partial enolization, instead of the desired nucleophilic addition [Scheme (46)].
Scheme (46)
In view of this, the reaction was repeated in the presence of an equimolar of zinc 
chloride, but this did not improve the required addition.
We note that Imamoto and his collaborators^* 78 report success when 
organocerium reagents, prepared in situ from cerium(HI) chloride and 
organomagnesium or organolithium reagents, are added to carbonyl compounds. 
In particular, it is claimed that these less basic reagents, react in good yields with 
those carbonyl compounds which are prone to side reactions, such as enolization.
Terashima et a/79-81 have also reported similar results when treating 
organocerium reagents with imines.
We decided to follow this work up and to carry out the reactions shown [Scheme 
(47)].
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RMgBr + CeClj RCeClj + MgBrCl
Scheme (47)
Using a procedure recommended by Kaesz^^ we formed the Grignard reagent 
from 3 -bromo-2-methylprop-2-ene and reacted it with cerium trichoride, but when 
this was combined with the imine, following Imamoto’s conditions only the imine 
was returned.
While this research was being undertaken another group **3, 84 reported similar 
difficulties when attempting the additions of organolithiums and organomagnesium 
bromides to imines in diethyl ether as solvent. For some unexplained reason these 
authors noted an increase in yield from 0 to 80% for the reaction of 
organomagnesium bromides to imines when the solvent was changed to toluene. 
However, in our case, such a switch was not advantageous and the best yield of the 
adduct (85) was only 15%.
Several weeks had now been expended on this problem and we concluded that we 
were only tinkering with at least two processes in equilibrium. It seemed 
appropriate to push on and accept that 31% was a reasonable yield of the adduct 
after all.
The next step in our projected synthesis was acid catalysed ring-closure. Previous 
work in the Department had shown that concentrated sulfuric acid is a satisfactory
reagent for this type of cyclisation and we assume that if it proceeds by initial 
protonation of the alkene side chain chemoselectivity is ensured as protonation at 
the terminal position gives a tertiary cation as an intermediate. Indeed, it is 
unlikely that anything other than a quinoline should form eventually, unless 
rearrangement of the double bond occurs. One effect of using strong acid as 
reagent is that the JV-protecting group was removed during the reaction.
The key intermediate (86) (R=Me) was obtained successfully (60%), along with 
the O-demethyl derivative (86) (R=H) by cyclisation of aniline (85) using 
concentrated sulfuric acid.
Once isolated, we attempted to synthesise some N-acylated derivatives from (86, 
R=Me) using a variety of coupling reagents. The first analogues to be investigated 
were compounds (50, a-d).
Treatment of the amine (86, R=Me) and the appropriate acid chloride in the 
presence of 4-dimethylaminopyridine (DMAP) and triethylamine afforded the 
compounds (50, a-c) in moderate yields of 28, 38 and 95 % respectively.
Of course, there are two basic amino centres in the spirotetrahydroquinolines, but 
one of these is an anilino type, far less reactive than the piperidino unit. The 
selection of these three amides rested on the fact that we wished to investigate 
structure-activity relationships with derivatives containing side chains of increasing
H R=(CH2)10CH3(c)





length, but from computer modelling studies it soon became apparent that simply 
increasing the length of the saturated alkyl chain allowed the chain conformational 
flexibility instead of remaining rigid. Since we wanted the ionisable portion of the 
compound to be freely accessible, it seemed necessary to synthesize the analogue 
(50d) where the flexibility of the chain is reduced by the inclusion of a double 
bond. Reacting amine (86) with oleoyl chloride using similar conditions as 
previously applied to compounds (50 a-c) resulted in the formation of the desired 
compound (50d) in 10 % yield.
Our next objective was to prepare two compounds, which would contain a similar 
functionality to the components of a known material “Tarabetic” Although 
designed as a drug for diabetes Tarabetic is also believed to act as an antioxidant. 
It contains y-linoleic acid (89) which is considered to be the key active ingredient.
CH3(CH2)4CH=CHCH2CH=CH(CH2)7COOH
(89)
With this in mind, it was deemed necessary for the author to prepare one 
compound containing an acid function, whilst the other should incorporate a 
linoleic side chain as shown:




The first compound (50e) was prepared successfully in 10% yield by reacting the 
amine (86) with 3,3-dimethylglutaric anhydride in the presence of DMAP and 
triethylamine in DCM.
The second compound (50f) was synthesised by treating amine (86) with linoleic
acid in the presence of 1,3 -dicyclohexylcarbodiimide ( D C C ) ^ .  Such a coupling
reagent has been used with much success in the formation of peptides 86 The 
mechanism for the reaction is shown [Scheme (48)].
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Analogue (50f) was initially isolated in 16% yield, but was found to be highly 
contaminated by dicyclohexyl urea. This by-product however, this could be 
removed by washing the product with cold ethyl acetate.
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It should be noted that little attempt was made to optimise the yields of all the 
amides since only small quantities of the products were required for biological 
testing.
At this point a company called Eirex approached us wishing to bring together work 
on antioxidants and diabetes. This company was extremely interested in evaluating 
the amides we had just synthesised and encouraged the University of Bath to 
patent the possible application effects of them. They paid for the cost of the patent 
application, which was duly filed and reserved the right to licence the patent if the 
compounds showed useful properties in their tests. The compounds themselves 
were evaluated at the University of Cork, but none of them showed sufficient 
activity against diabetes and other indications to warrant follow-up work. Thus the 
project was dropped.
Unfortunately for us in the process of assessment at Cork all of our stocks of the 
amides were consumed and we still do not know how these compounds might have 
behaved in a trial specifically designed to assess their selectivity for LDL.
The work with Eirex focussed our attention on diabetes and in particular upon the 
drug troglitazone (96), which in addition to its action against this condition also




It seemed to us that the main structural unit of troglitazone might also serve as a 
/^-substituent of the piperidino group of the spirotetrahydroquinolines. 
Consequently we took on the synthesis of the amide (50g) and attempted the 
reaction sequence shown [Scheme (49)].
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The 2,4-thiazolidinedione (98) was prepared in high purity (98%) by a 
Knoevenagel condensation between methyl 4-formylbenzoate and 2,4- 
thiazolidinedione in boiling toluene, using a catalytic amount of piperidinium 
acetate.
Once obtained, the product was hydrogenated to give the benzyl-2,4 
thiazolidinedione (99) in 72% yield.
Having formed the two halves of our target molecule we were now in a position to
attempt a coupling between them. In 1996, Gotor and co-workers** 8> 89 reported 
success using Candida antartica Lipase (CAL) as a catalyst for the asymmetric 
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We decided to use a similar enzymatic approach to effect coupling on our substrate 
as shown [Scheme (51)]. However, this failed and a TLC analysis of the reaction 
mixture only revealed the presence of unreacted starting material. Other
e n z y m e s ^ O  recommended for similar types of couplings were also tried, but the 
results were all the same.
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We are unsure why this reaction failed, although we recognised that our substrates 
are much more complicated than those normally used in enzymic amidolysis 
reactions.
Attempts to combine the benzyl-2,4-thiazolidinedione with the piperidine (86) 
using sodium hydride to deprotonate the latter were also unsuccessful and a 
quantitative amount of unreacted tetrahydroquinoline was returned after work up. 
We were unsure of the reason for this failure and decided to move to an alternative 
approach. In particular, we decided to hydrolyse the ester (99) to the 
corresponding acid (102). Once prepared, we anticipated using a peptide coupling 







In order to achieve our goal, we reacted benzyl-2,4-thiazolidinedione (99) with a 
dilute aqueous solution of sodium hydroxide. However, these conditions proved 
too harsh as further degradation occurred. From NMR we noted that the 
thiazolidine ring was no longer intact and it seemed possible that the 
mercaptoamide (103) had formed. Enzymatic hydrolysis conditions were also 
attempted but these also failed.
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The final approach was to treat the ester (99) with trimethylsilane iodide (TMSI),
followed by subsequent hydrolysis. Such a reaction was first reported by Olah^l. 
With our substrate, however, the ester group remained unreactive and even after a 
reaction time of 35 h in boiling acetonitrile work up gave an almost quantitative 
return of starting material.
As a consequence of the negative results obtained so far, we decided to move to
the benzyl ester^  as one could envisage the ester group being cleaved during the 














Initially, following the procedure of Hassner^ we reacted 4-formylbenzoic acid 
with benzyl alcohol in the presence of DCC and a catalytic amount of N- 
pyrrolidinopyridine in DCM. The desired ester (105) was obtained pure in 10% 
yield although originally it was contaminated with dicyclohexyl urea. Next 4- 
formylbenzoic acid was treated with sodium hydrogen carbonate and then with 
benzyl bromide. The desired benzyl ester (105) was isolated in 28% .
More traditional methods of esterification might well have been assessed, but in the 
meantime we attempted a Knoevenagel reaction between it and the 
thiazolidinedione. The initial reaction was one in which benzyl 4-formylbenzoate 
and 2,4-thiazolidenedione were heated in toluene with a catalytic amount of 
piperdinium acetate. Previously when the methyl ester (99) had been used the • 
condensation worked well. Now the analogous reaction failed. It is probable that 
the benzyl ester is susceptible to enolisation under the basic conditions we 
employed and a self-aldolisation-type process is now competitive with 
condensation with the thiazolidinedione.
At this point the news from Eirex about the simpler amides was relayed to us and 
the author was instructed not to pursue this particular work further.
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5.0 The Imidazolidines
One problem we continually faced in previous work was low yields in key 
reactions. Thus, we wanted to devise a high yielding route to antioxidants that 
would enable us to obtain rapidly reasonable amounts of materials for biological 
assessment. We were therefore attracted to the benzimidazoline system as a 
replacement for the tetrahydroquinoline unit. In particular, we considered 
compounds of the type (107), where the oxidisable “head” is the 1,2- 
phenylenediamine moiety and the lipophilic tail is a spiropiperidine assembly as 
before.
Benzimidazolidine derivatives are often synthesised by a dehydration condensation 
reaction between 1,2-phenylenediamine and carbonyl compounds. It is known that 
this reaction is reversible and removal of generated water is required to complete 
the reaction. Aldehydes are common co-reagents in the cyclisation, but in general 
ketones are much less useful. However, imidazolidine formation has been reported
when ethylenediamine is treated with c y c l o h e x a n o n e ^ .  i n  our hands we 
attempted to react the phenylenediamine (108) with the piperidone (109) under 
Dean-Stark conditions in the anticipation of forming the imine (110). Once 




appropriate conditions to afford the key intermediate (112). After isolation, 
deprotection and peptide coupling with an appropriate substrate we might thus 
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PG = Boc or Ac
Scheme (53)
In practice, commercially available A-Boc protected 4-piperidone (109) was 
allowed to react under Dean-Stark conditions with 4,5-dimethyl-1,2- 
diaminebenzene (108), formed previously by the hydrogenation of 2-nitro-4,5- 
dimethylaniline.
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After 4 h TLC analysis of the reaction mixture showed the formation of a new 
compound, which was presumed to be the imine (110). This was prompted by the 
electronic spectrum, which revealed a band at A™* = 285 nm. When sodium 
borohydride was added to the UV sample, this band disappeared. Unfortunately 
this seemed to be the end of the reaction since the electronic spectrum of the 
reaction mixture at the end of a 24 h period at reflux had not changed from that 
after 4 h.
In light of this result we repeated the experiment with a catalytic amount of 4- 
toluenesulfonic acid added to promote cyclisation of the presumed imine. The end 
result was the same however, and further attempts to induce cyclisation by 
increasing the amount of acid also proved unsuccessful.
In 1984, Suschitzky and c o - w o r k e r s ^  reported the preparation of a closely related 
compound (114, R=H) by heating 1,2-phenylenediamine (108, R=H) with 
cyclohexanone in water at reflux for a period of only 10 mins.
We were pleased to discover that when this procedure was repeated using 4,5- 
dimethylphenylendiamine (108, R=Me) the corresponding benzimidazolidine (114, 






The successful synthesis prompted us to examine the possibility of using the TV- 
protected piperidone (115) and indeed this led to our target compound (111), but 
in only 26% yield.
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Once isolated, deprotection of the nitrogen atom of the product was attempted. 
Treating the benzimidazolidine (111) with a solution of TFA:DCM (1:1) however, 
proved unrewarding. TLC analysis of the reaction mixture revealed the presence 
of a multi component mixture. This was not surprising as it is known that 
imidazolidines readily hydrolyse in the presence of acids to afford the 
corresponding aldehyde and diamine of synthesis. However, such a functionality is
reported to be more stable in the presence of alkali^
In light of this, we decided to repeat the ring-forming reaction using N- 
acetylpiperidone (116), and when TV-acetylpiperidone (116) was heated with 4,5- 
dimethylphenylenediamine (108) under the same conditions as that adopted 












The next step was the removal of the acetyl group. This was attempted by stirring 
the parent compound (117) in the presence of aqueous 10% potassium carbonate 
for 2 h. However, TLC analysis of the reaction mixture revealed many compounds 
with similar Rf values; these could not be separated by column chromatography on 
silica.
It was only after we had the A-acetyl and A-Boc protected benzimidazolidines in 
our possession for a few days that we realised they were unstable and we consider 
that they revert back initially to the corresponding 2-iminoanilines. From here 
these products decompose further, probably through hydrolysis in moist air, to the 




This instability is not acceptable in a potential drug and further work in the area 
was stopped, especially as we discovered that chemists at Astra Sweden had 
worked on related benzimidazolidines and discovered them to be unsatisfactory in 
their test regimes.
We next turned to analogues where no spiro centre exists and we selected the 
“open” chain 1,2-phenylenediamines (122) where, as before, R could be groups of 
variable lipophilicity. The initial synthetic strategy employed is shown [Scheme 
(58)].
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The first step involved treating the 1,2-phenylenediamine (108) with N-Boc glycine 
(118) in the presence of DCC. Although this coupling proved successful the 
maximum yield was only 22 %.
It is well known that a major side reaction encountered with carbodiimides is O-N- 
acyl migration as shown in [Scheme (59)] and we considered that this may well 
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Scheme (59)
To overcome this problem, a number of different reagent systems have been 
developed. One such is the use of 1-hydroxybenzotriazole (HOBt), which in the 
presence of carbodiimides promotes only iV-acylation. The role of the triazole is to 
form an O-acyl derivative by an exchange with the acylated diimine and it is this 
which reacts with the amine.
H+
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Scheme (60)
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When this reagent combination was used with iV-Boc glycine (118) and the 
dimethylphenylenediamine (108) we obtained the desired product (119) in 30 % 
yield. However, it was highly contaminated by dicyclohexylurea which proved 
very difficult to remove. In view of this, we decided to explore another coupling
reagent. Initially 1 -ethyl-3-(3-dimethylamino)propylcarbodiimide (EDC)^6 was 
chosen. This reagent has the advantage that all the coupling reagent by-products 
can be washed out easily using an aqueous or acid workup.
Reacting the phenylenediamine (108) and N-Boc glycine (118) in the presence of 
EDC in DCM resulted in a substantial increase in the yield of the product that was 
formed from 30 to 73%.
Having obtained the Boc protected diamide (119) in. good yield, A-deprotection m 
was performed by treating it with a solution of TFA:DCM (1:1) for 2 h. This 
afforded the deprotected diamide (120) in 44 % yield).
The next step in the synthesis involved the reduction of the diamide (120) to the 
tetraamine. An initial attempt using excess diborane in THF at reflux proved 
unrewarding. Even after 20 h, only starting material was isolated.
Next, lithium aluminium hydride in refluxing THF was employed but this gave a 
multi-component mixture that proved impossible to separate by column 
chromatography.
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Turning to the literature we noted that Ito et al.97 had reported success when
reducing tertiary amides to the corresponding amines with hydrosilanes in the 
presence of rhodium complexes. Although the actual mechanism is still under 
investigation, it is thought that the catalytic cycle involves oxidative addition of 
hydrosilane to a Rh(I) complex [Scheme (61)]. In the process the Rh(I) complex is 
converted into a hydrido(silyl)rhodium(III) species, (124), which undergoes 
insertion of the amide substrate. The carbon of the amide is bonded to the Rh 
metal and silicon migrates to oxygen. Rapid intermolecular hydride transfer leads 
to reductive clevage of the O-Si bond and finally the reagent is reformed as an 















In our hands however, treatment of diamide (120) with 0.1 mol% RhH(CO)(PPh3)3 
in THF in the presence of Ph2SiH2 at room temperature led to the disappearance of 
starting amide, but we could not isolate the product. This probably reflects the 
highly soluble nature of the very basic tetraamine. Indeed, on reflection we began 
to realise how difficult the obtention of such a compound might be and that a more 
realistic aim might be to form the required diamides by reductive animation using a 
precursor in which the side chain amino groups already contained the amide units 
in place. Initially we considered the synthesis of the lauroyl derivative (127), but 
first it was necessary to prepare the intermediate amidoaldehyde (128). The three 
step synthesis is outlined below:
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Step one involved reacting ethanolamine with lauroyl chloride in the presence of 
DMAP and triethylamine in DCM. This was indeed successful, affording the 
hydroxyamide (127) in 70% yield, which we next attempted to oxidise to the 
corresponding aldehyde (128). This was achieved by treatment of the amido 
alcohol (127) with pyridinium chlorochromate (PCC). After 1 h IR spectroscopy 
of the reaction mixture revealed the formation of the desired aldehyde as indicated 
from an extra absorption peak at Vmax 1740 cm'1 . It soon became apparent 
however, that if the reaction mixture was left for a longer period of time e.g. 5 h, 
the formation of the corresponding acid took place as evidenced by the appearance 
of a new broad signal centred at Vmax -  3320 cm'1. J t should be noted that an m
alternative approach, treating the alcohol (127) with a solution of oxalyl chloride 
and DMSO, also resulted in the formation of the corresponding acid, this time as 
the sole product.
As a solution of the aldehyde rapidly oxidised in air it was essential that it was used 
directly without purification in the reductive animation step. Reacting two 
equivalents of aldehyde (128) with the diamine (108) in the presence of freshly 
fused sodium acetate, freshly activated molecular sieves and sodium 
cyanoborohydride afforded a dark oil. This contained several components, which 
ran closely together on a TLC plate.
An alternative approach would be to carry out the alkylation of the 
phenylenediamine with the alkyl bromide formed from the amidoalcohol (127).
I l l






Treating alcohol (127) with freshly distilled phosphorus tribromide afforded a 
yellow solution, which was rapidly quenched on addition of ice water giving only 
returned amidoalcohol (127). It now seems likely that hydrolysis of the bromo 
derivative occurs extremely rapidly and had we time to pursue this project further 
it would have been necessary to use it in the crude form without isolation or 
treatment with water.
The unsatisfactory end of this work coincided with disappointment in the testing 
programme. After £20 million had been spent upon developing antioxidants of the 
indenoindole and indoline types Astra and Eirex decided to pull out of further work 
in the area.
It was not a question of lack of antioxidant effect, it was a general feeling of the 
industry that antioxidants in general, might not deliver the protection they once 
seemed to offer. Vitamin E itself as a supplement to human diet had been shown 
to act as a promoter as well as an inhibitor of radical processes. Probucol the lead 
compound in the area had to be withdrawn several years before and unfortuantely 
Astra’s own animal studies failed to show a major reduction of plaque 
development in the Watanbe rabbit. These conclusions and considerations brought 
the whole synthetic programme to an end.
6.0 Experimental
Chemicals, solvents and reagents were purified and dried, where appropiate, before 
use by standard methods. ‘Petrol’ refers to Petroleum ether boiling in the range 
40-o0°C.
Column chromatography was performed using Amicon Matrix 60A silica gel under 
medium pressure using a small hand bellow. Thin layer chromatography (tic) was 
performed on Whatman pre-coated glass plates. Visualisation was achieved by 
illumination under a short wavelength (254nm) ultra violet light where possible.
Melting points were determined on Electrothermal MK HI apparatus and are • 
uncorrected. Mass spectra were recorded using a Finnigan MAT 8340 magnetic 
mass spectrometer. Infa-red (IR) spectra were measured as liquid films and 
recorded in the range 4000-600cm‘1 using a Perkin Elmer 1605 FT-IR 
spectrometer.
and 13C nuclear magnetic resonance spectra were recorded on a Jeol GX270 
(270MHz) or Jeol GX400 (400MHz) spectrometer. For the 13C, the operating 
frequency was 67.8mHz, using 90° and 135° DEPT pulse sequences to aid 
multiplicity determinations. Samples were prepared in solutions of deuterated 
chloroform or DMSO. 5 values are expressed as parts per million downfield from 
tetramethylsilane as internal standard and coupling constants (J) in Hz.
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Trans-2.3,4.4a«5.6,11,11 b-Octahvdro-8-isopropyl-1 H-benzo \a\carbazole (14) 
and 1.2.3,,4,4a,5,6,7-Octahvdro-11-isopropylbenzo f d\ carbazole ( \ l \ ^
H
(12)
4-Isopropylphenylhydrazine hydrochloride (lOg, 53mmol), 1 decalone (8g, 8.2cm3, 
53mmol), freshly fused sodium acetate (8.6g, 106.7mmol) and glacial acetic acid 
(75cm3) were heated in an oil bath firstly at 60°C for *30 mins and then at 110°C 
for 2 h. The solvent was removed and residue partioned between ethyl acetate and 
water. The organic layer was collected, washed with brine 20cm3 (x2) and then 
saturated sodium hydrogen carbonate 20cm3 (x2), dried and evaporated. The 
residue was triturated with light petrol and the solid which formed was collected 
and washed sparingly with light petrol, until the filtrate was almost colourless. The 
colourless powder (7.0g) that remained consisted of a 2:1 mixture of indolenine 
(12) and indole (14). This mixture could be separated with difficulty by repeated 
crystallisation. The washings and filtrate were combined and evaporated to afford 
a brown oil (6.2g) which was chromatographed on silica gel, eluting with 4% ethyl 
acetate in petrol to afford the indole (14) as a pale yellow unstable oil (1.5g, 11%), 
Vmax/cm * 3406cm'1,8 H (CDC13); 1.2 (2H, m),1.3 (6H, d, J= 6.7, ;Pr), 1.3-2.2 (11H, 
m), 2.6-2.9 (1H, m), 3.0 (1H, sept, J= 6.7, 'Pr-CH), 7.0 (1H, dd, J= 8.2, 1.7, Ar­
il), 7.2 (1H, d, J= 8.2, Ar-H), 7.3 (1H, d, J= 1.7, Ar-H) 8C (CDC13); 21.2 (2H),
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24.8 (6H), 26.3 (2H), 26.4 (2H), 30.1 (2H), 30.9 (2H), 33.2 (2H), 34.3, 40.7,
41.8, 109.3, 110.3, 114.8, 120.0, 127.8, 134.3, 137.7, 140.0. m/z (El) % 267.2 
(30, NT).
Further elution with 4% ethyl acetate in petrol gave more of the indole (14) 
contaminated with another component and elution with 20% ethyl acetate in petrol 
then yielded the indolenine (12) as an oil (4.2g, 30%), Vmax/cm'1 1610cm'1 (C=N),
8h (CDC13); 1.0 (1H, brd, >11.5), 1.3 (6H, d, > 7 .0 , Tr), 1.4-1.8 (7H, m), 2.0-2.2 
(5H, m), 2.6 (1H, ddd, >13.0, 13.0, 5.5), 2.80 (1H, dddd, >13.6 , 5.5, 2.5, 2.5),
3.0 (1H, sept, > 7 .0 , TrCH), 7.2(1H, dd, > 7 .9 , 1.8, Ar-H), 7.5 (1H, d, > 7 .9 , Ar­
if), 7.6 (1H, d, > 1 .5 , Ar-H), 8C (CDC13);. 19.9 (2H), 21.6 (2H), 24.5 (6H), 26.4 
(2H), 27.1 (2H), 27.4 (2H), 28.3 (2H), 29.4 (2H), 343 , 41.1, 57.5, 119.8, 123.0, .




A solution of the indolenine (22) (0.4g, 0.8mmol), di-/^r/-butyldicarbonate (0.4g, 
1.6mmol) and freshly fused sodium acetate (O.lg, 1.6mmol) were dissolved in THF
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and stirred under nitrogen for a few mins. The reaction was then left to stir at 60- 
70°C for 5 weeks over which time a further 6 equivalents of di-tert- 
butyldicarbonate were added. On completion the tetrahydrofuran was removed in 
vacuo and the resultant viscous brown oil was taken up in ethyl acetate (40cm3) 
and washed with water 10 cm3 (x2) and brine 10cm3 (x2). The organic phases 
were combined, dried and evaporated to afford a brown oil, which was 
chromatographed on silica gel, eluting with 4% ethyl acetate in petrol to afford the 
title compound as a viscous colourless oil (0.13g, 36%), VmaxCm'1 1713cm'1, 6h 
(CDC13); 1.0 (1H, m), 1.3 (6H, d, .7=7.0, ‘Pr), 1.5 (9H, s, *Bu), 1.5-2.4 (12H, m),
2.9 (1H, hept, .7=7.0, ‘PrCH), 5.9 (1H, bs, 7-H), 7.1 (1H, m, Ar-H), 7.4 (1H, d,
J= 1.6, Ar-H), 7.6 (1H, d, J= 8.2, Ar-H), 5C (CDCI3);. 20.2 (2H), 20.8 (2H), 23.6 .
(2H), 24.4 (2H), 27.3 (6H), 27.8 (9H), 28.9 (2), 34.0 (2H), 33.8, 34.7, 45.3,
108.3, 115.1, 123.0, 124.5, 138.5, 139.2, 142.5, 145.8, 146.7, 151.7, 152.1. m/z 
(FAB) % 367.3 (M*+l, 40).
Found: m/z (FAB) 367.251663, C24H33NO2, (N^+l) requires : 367.251130. 
6-Isopropyl l,2.3«4-tetrahvdro-4a-methvI-carbazoIe (221
The 4-isopropylphenylhydrazine hydrochloride (5.0g, 3 3 mmol), 2-methyl 
cyclohexanone (3.7g, 4cm3, 33mmol), freshly fused sodium acetate (4.6g, 66mmol) 
and glacial acetic acid (40cm3) were heated in an oil bath firstly at 60°C for 30
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mins and then at 110°C for 2 h. The solvent was removed and residue partioned 
between ethyl acetate and water. The organic layer was collected, washed with 
brine 10cm3 (x2) and then with saturated sodium hydrogen carbonate 10cm3 (x2), 
then dried with magnesium sulfate. The organic layers were combined and 
evaporated to afford a brown oil which was chromatographed on silica gel, eluting 
with 30% ethyl acetate in petrol to afford the title compound as a pale yellow oil 
(5.1g, 68%), W c n f 1 1582.6cm'1 (C=N), 5H (CDC13); 1.3 (6H, d, 7=7.0, Tr), 1.3 
(3H, s, Me), 2.6 (1H, m), 2.9 (1H, m), 3.0 (1H, hept, 7=7.0, ‘PrCH), 7.2 (1H, d, 
7=1.8), 7.2 (1H, dd, 7=7.9, 1.8), 7.5 (1H, d, 7=7.9), 6C (CDC13); 19.7 (3H), 21.2 
(2H), 24.2 (6H), 28.9 (2H), 29.4 (2H), 34.0, 38.5 (2H), 53.5, 119.2, 119.5, 125.3,
145.7, 146.6, 151.9, 189.4. m/z (El) % 227.2 (40, M+),
Found : m/z (El) 227.167297, CieHziN (M*) requires : 227.167400.
Synthesis of 1.2.3,4 tetrahvdro-6-isopropvl-9-fe/t-butoxvcarbonvl-4a-methvl- 
carbazole (231
A solution of the indolenine (22) (0.5g, 2.2mmol), di-ter/-butyldicarbonate (0.48g, 
2.2mmol) and freshly fused sodium acetate (0.15g, 2.2mmol) were dissolved in 
THF and stirred under nitrogen for a few mins. The reaction was then left to stir at
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60-70°C for 3 days over which time a further equivalent of di-tert-butyldicarbonate 
was added. On completion of the reaction the tetrahydrofuran was removed in 
vacuo and the resultant viscous brown oil was taken up in ethyl acetate (40cm3) 
and washed with water 15cm3 (x2) and then brine 15cm3 (x2). The organic phases 
were combined dried and evaporated to afford a brown oil, which was 
chromatographed on silica gel, eluting with 4% ethyl acetate in petrol. This 
afforded the title compound as a viscous colourless oil (0.37g, 51%) Vmax/cm'1 
1713cm'1 (C=0), 5h (CDC13); 1.2 (6H, d, 7=7.0, ‘Pr), 1.3 (3H, s, Me), 1.6 (9H, s, 
lBu), 1.6-2.3 (6H, m), 2.9 (1H, hept, J= 7.0, ‘PrCH), 5.9 (1H, bs, 7-H), 7.0 (1H, d, 
7=2.0), 7.03 (1H, dd, 7=1.7, 1.8), 7.6 (1H, d, 7=8.2), 6C (CDC13); 17.5 (2H), 23.0 
(2H), 24.2 (3H), 24.2 (3H), 27.7 (3H), 23.4 (9H), 31.4 (2H), 33.8, 41.6, 81.5, •
107.2, 115.0, 119.4, 124.9, 138.7, 139.6, 143.8, 145.2, 151.8, m/z (FAB) % 327.2 
(50, M*+l).
Found: m/z (El) 327.220276, C2iH29N 02(M Vl) requires : 327.219829. 
1.2.3.4.9.9a-Hexahvdro-6-isopropyl-4a-methvlcarbazole (25)
H
Indolenine (22) (1.5g, 6.6mmol) was placed in tetrahydrofuran (10cm3), then 
sodium borohydride (0.25g, 6.6mmol) was added portionwise. The reaction 
mixture was then left to stir overnight. On completion of the reaction a solution of
118
1M sodium hydroxide (5cm3) was added. The tetrahydrofuran was removed in 
vacuo and the resultant viscous brown oil was taken up in ethyl acetate (40cm3) 
and washed with water 5cm3 (x2) and brine 5cm3 (x2). The organic phases were 
combined, dried and evaporated to afford a brown oil which was chromatographed 
on silica gel, eluting with 10% ethyl acetate in petrol to afford the title compound 
as a pale yellow oil (3.0g, 40%), 8H (CDC13); 1.2 (6H, d, 7=6.8, Pr), 1.3 (3H, s, 
Me), 1.3-1.7 (8H, m), 2.8 (1H, hept, 7=6.8, ‘PrCH), 3.4 (1H, t, 7=4.3), 6.6 (1H, d, 
7=8.3, Ar-H), 6.87 (1H, s, Ar-H), 6.9 (1H, d, 7=2.0, Ar-H), 8C (CDC13); 21.1 
(2H), 21.4 (2H), 24.2 (3H), 27.4 (2H), 35.0 (3H), 35.3 (3H), 42.7 (2H), 60.3, 
66.0, 109.8, 119.6, 124.5, 139.5, 139.6, 147.3. m/z(EI)% 229.2 (60, IVT).
Found : m/z (El) 229.183064 C^H^N (M*) requires 229.183050.
Preparation of A-Boc -9a-hvdroxv-6-isopropyl-4a-methvl-l-bromo- 
E2,3A4a,9-hexahvdrof9aHlcarbazole (301
The te/7-butoxycarbonyl protected carbazole (23) (0.17g, 0.5mmol) was placed in 
DCM (10cm3). A-Bromosuccinimide (O.lg, 0.5mmol) was added in one portion 
and catalytic hydrogen peroxide was added dropwise (0.1cm3, 27% solution in 
water). The reaction was then left to stir at room temperature for 16 h. The
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reaction mixture was quenched with water, extracted with ethyl acetate and dried 
in vacuo. Column chromatography on silica gel, eluting with 10% ethyl acetate in 
petrol yielded the title compound as an oil (O.Olg, 4.7%), 5h (CDCI3); 0.9 (1H, m), 
1.2 (6H, d, 7= 7.1 ‘Pr), 1.3 (3H, s, Me), (1.6-1.7 (1H, m), 1.7-2.2 (4H, m), 2.9 (1H, 
hept, 7=7.1, ‘PrCH), 4.2 (1H, t, 7=4.8, CHBr), 7.1 (1H, dd, 7=7.9, 1.8, Ar-H), 7.2 
(1H, d, 7=1.8, Ar-H), 7.4 (1H, brs, Ar-H), 8C (CDC13); 23.6 (2H), 24.6 (6H), 27.6 
(3H), 28.9 (9H), 28.9 (2H), 30.2 (2H), 34.3, 50.8, 82.6, 117.4, 119.5, 125.6,
126.5, 136.6, 144.8. m/z (FAB) 425.1/427.2 (40, 40, M*+l)





To a solution of the indolenine (22) (0.2g, 0.9mmol) in DCM (10cm3) was added 
A-bromosuccinimide (0.16g, 0.9mmol) and a catalytic amount of hydrogen 
peroxide (0.1cm3, 27.5% solution in water). The reaction mixture was then left to 
stir for a further 16 h before being poured into water. The organic layer was 
separated and the residue extracted with DCM 5cm3 (x2). The combined organic 
layer and extracts were then dried and evaporated to afford a brown oil which was 
chromatographed on silica gel, eluting with 30% ethyl acetate in petrol. This gave
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the title compound as a pale yellow oil (0.08g, 29%), 8h (CDCI3); 1.3 (6H, d, 
.7=7.0, ‘Pr), 1.3 (3H, s, Me), 1.4-1.5 (2H, m), 1.7-1.8 (2H, m), 2.2-2.3 (2H, m), 2.6 
(1H, m), 2.9 (1H, m), 2.9 (1H, hept, 7=7.0, ‘PrCH), 7.1 (1H, d, 7=1.5, Ar-H), 7.3 
(1H, d, 7=1.5, Ar-H), 8C (CDC13); 19.8 (3H), 21.2 (2H), 24.1 (6H), 28.8 (2H), 
29.7 (2H), 33.9, 38.6 (2H), 55.4, 113.4, 118.5, 128.6, 147.7, 148.4, 150.4, 190.8. 
m/z (El) % 305.0/307.1 (30, 30, M*)
Found m/z (El) 305.078003/307.07560 Ci6Hi9NBr (M*) requires 
305.077911/307.07601.
Method 2
To a solution of the indolenine (22) (l.Og, 4.4mmol) in dry chloroform (10cm3) 
was added aluminium trichloride (O.lg, 0.7mmol). The reaction mixture was left 
to stir at 0°C for 15 mins before the addition of bromine (0.7g, 0.23cm3, 4.4mmol). 
The solution was left to stir for 2 h at 0°C and for a further 2 h at room 
temperature. The solution was then washed with sodium hydrogen sulphate 5cm3 
(x2). The organic layer was removed and the residue was extracted with DCM 
5cm3 (x2). The organics were combined and evaporated to afford a brown oil 
which was chromatographed on silica gel, eluting with 10% ethyl acetate in petrol. 
This gave two products, which could not be separated.
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Attempted ortho-lithiation of 8-Bromo-l,2,3,4-tetrahvdro-6-isoproDvl-4a-
methvlcarbazole (34)
Br
Bromoindolenine (33) (0.2g, 0.7mmol) was placed in ultra dry THF (10 cm3). 
TMEDA (0.2cm3, 1.4mmol) was then added. After a few mins «-butyllithium 
(0.4cm3, 2.5M in hexanes) was added dropwise at -78°C. The solution was left to 
stir at -78°C for 2 h, before quenching with excess allyl chloride (1cm3, 7.0mmol). • 
The tetrahydrofuran was removed in vacuo and the resultant viscous yellow oil 
was taken up in ethyl acetate (20cm3) and washed with water 5cm3 (x2) and brine 
5cm3 (x2). The organic phases were combined, dried and evaporated to afford an 
oil which was chromatographed on silica gel, eluting with 20% ethyl acetate in 
petrol to afford the debrominated compound (22) as a pale yellow oil in 
quantitative yield, 5H (CDC13); 1.3 (6H, d, 7= 7.0, {Pr), 1.3 (3H, s, Me), 2.6 (1H, 
m), 2.9 (1H, m), 3.0 (1H, hept, 7= 7.0, ‘PrCH), 7.2 (1H, s), 7.2 (1H, dd, J=1.8, 
6.1), 7.5 (1H, d, 7=7.9), 8C (CDC13); 19.7 (3H), 21.2 (2H), 24.2 (6H), 28.9 (2H),
29.4 (2H), 34.0, 38.5 (2H), 53.5, 119.2, 119.5, 125.3, 145.7, 146.6, 151.9, 189.4. 





Triphenylphosphine (O.lg, 1.2mmol) and 10% palladium (II) acetate (0.0125g) in 
freshly distilled toluene (10cm3) were stirred for a few mins under nitrogen. 
Triethylamine (O.lg, 0.1cm3, 0.86mmol) was then added dropwise. The bromo • 
compound (33) (0.12g, 0.39mmol) in toluene (5cm3) was added before addition of 
methyl acrylate (0.04g, 0.04cm3, 0.39mmol). The reaction mixture was left to stir 
at 80°C for 2 days. After this time the reaction mixture was poured into water.
The organic layer was extracted and the residue washed with DCM 5cm3 (x2).
The organic phases were combined, dried and evaporated to afford a brown oil 
which was chromatographed on silica gel, eluting with 30% ethyl acetate in petrol.
This gave the title compound as a pale yellow oil (0.05g, 41%), 8H(CDCl3); 1.27 
(6H, m, ‘Pr), 1.74 (4H, m), 2.2 (2H, m), 2.6 (1H, m), 2.9 (1H, hept, 7=7.0 
(iPrCH), 3.81 (3H, s, OMe), 6.9 (1H, d, 7=16.1), 7.2 (1H, d, 7=1.7, Ar-H), 7.4 
(1H, d ,7=1.7, Ar-H), 8.3 (1H, d ,7=16.1), 5c (CDCl3); 19.9 (3H), 21.3 (2H), 24.2 
(6H), 29.0 (2H), 29.8 (2H), 34.1, 38.6 (2H), 51.5 (3H), 53.6, 119.5, 121.1, 124.2,
125.8, 141.4, 146.0, 148.5, 151.7, 167.7, 190.5. m/z (FAB) % 312.3 (100, M*+l) 




To a solution of the indolenine (12) (1.27g, 4.8mmol) in DCM (20cm3) was added 
/V-bromosuccinimide (0.85g, 4.8mmol) and a catalytic amount of hydrogen 
peroxide (0.5cm3, 27.5% solution in water). The reaction mixture was then left to 
stir over the weekend before pouring into water. The organic layer was extracted 
and the residue washed with DCM 5cm3 (x2). The organic phases were combined, 
dried and evaporated to afford a brown oil, which was chromatographed on silica 
gel, eluting with 30% ethyl acetate in petrol. This gave the title compound as a 
pale yellow oil; (0.25g, 15%), 8H (CDC13); 1.0 (1H, brd, >12.6), 1.28 (6H, d, 
> 7 .0 , ‘Pr), 1.4-1.8 (7H, m), 2.0-2.2 (5H, m), 2.6 (1H, m), 2.9 (2H, m), 7.4 (1H, d, 
>1 .5), 7.5 (1H, d, >1.5); 8C (CDC13); 20.1 (2H), 21.8 (2H), 24.7 (6H), 26.7 
(2H), 27.5 (2H), 27.7 (2H), 28.5 (2H), 29.9 (2H), 34.5, 41.6, 59.6, 114.1, 122.3,
128.8, 146.8, 147.5, 150.9, 191.0. m/z (El) % 345.1/347.3 (100, 100, M*).





Triphenylphosphine (0.9g, 3.3mmol) and 10% palladium (II) acetate (0.013g) in 
freshly distilled toluene (10cm3) were stirred for a few mins under nitrogen. 
Triethylamine (0.24g, 0.3cm3, 2.4mmol) was then added dropwise. The bromo 
compound (36) (0.39g, l.lmmol) dissolved in toluene was added before the 
addition of methyl acrylate (0.09g, 0.1cm3, l.lmmol). The reaction mixture was 
left to stir at 80°C for 2 days. It was then quenched with water. The organic 
phases and washings were combined and evaporated to afford a brown oil, which 
was chromatographed on silica gel, eluting with 30% ethyl acetate in petrol to 
afford the title compound as a pale yellow oil (0.05g, 41%), 8h(CDC13); 1.0 (brd, 
1H, 7=11.9), 1.3 (6H, d, 7=7.0), 1.4-2.2 (12H, m), 2.6 (1H, m), 2.9 (2H, m), 6.9 
(1H, d, 7=16.1), 7.4 (1H, d, 7=1.7), 7.6 (1H, d, 7=1.7), 8.3 (1H, d, 7=16.1), 8C 
(CDC13); 19.7 (2H), 21.5 (2H), 24.2 (6H), 26.4 (2H), 27.1 (2H), 27.4 (2H), 28.3 
(2H), 29.5 (2H), 34.2, 41.1, 51.5 (3H), 57.5, 119.1, 123.5, 124.5, 141.4, 144.9,
146.7, 152.1, 167.7, 190.5. m/z (El) % 351.3 (45, IVT).









To a solution of the indolenine (12) (1.27g, 4.8mmol) in DCM (20cm3) was added 
/V-bromosuccinimide (0.85g, 4.8mmol) and a catalytic amount of hydrogen 
peroxide (0.5cm3, 27.5% solution in water). The reaction mixture was then left to 
stir over the weekend before pouring into water. The organic layer was extracted 
and the residue washed with DCM 5 cm3 (x2). The organic phases were combined, 
dried and evaporated to afford a brown oil, which was chromatographed on silica 
gel, eluting with 30% ethyl acetate in petrol. This gave a mixture of compounds 
(38) and (39) which could not be separated by column chromatography 5h 
(CDC13); 1.2 (2H, brd), 1.3 (14H, m), 1.4-1.8 (16H, m), 2.1-2.2 (2H, m), 2.5 (2H, 
m), 2.9 (3H, m), 4.4 (1H, m), 4.7 (1H, m), 5.4 (1H, m), 7.4 (2H, d, >1 .5), 7.5 




The ester (37) (0.2g, 0.6mmol) was taken up in 2M sodium hydroxide solution 
(15cm3) and left to stir at 60°C for 2 h. The reaction mixture was cooled and 
filtered through a pad of celite. The mixture was then cooled with ice before 
addition of concentrated hydrochloric acid. Ethyl acetate was then added and the 
organic layer was extracted with water 10cm3 (x2). The organic phases were 
combined, dried and evaporated to afford the title compound as a pale yellow oil 
(0.08g, 40%), 8h(CDC13); 1.2 (1H, brd,J=11.5), 1.3 (6H, d,J=6.8), 1.5-2.1 (12H, 
m), 2.6 (1H, m), 2.9 (1H, m), 3.6 (1H, m), 6.5 (1H, d, J=15.9), 7.5 (1H, s), 7.6 
(1H, s), 8.7 (1H, d, .7=15.9), 8C (CDC13); 19.7 (2H), 21.4 (2H), 24.3 (6H), 26.4 
(2H), 27.1 (2H), 27.3 (2H), 28.3 (2H), 28.5 (2H), 34.3, 41.5, 57.4, 120.0, 122.4,
124.6, 126.0, 141.0, 145.5, 146.2, 169.6, 192.5, m/z (FAB) 338.1 (100, M++1).
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9-Allvl-1.2.3.4«9,9a-Hexahvdro-6-isopropyl-4a-methvlcarbazo1e (42)
To a stirred solution of sodium hydride (0.07g, 1.5mmol of 60% in oil dispersion) 
in DMF (20cm3) was added at 0°C under nitrogen the carbazole (41) (0.28g, 
1.2mmol) in diy DMF. After the addition, the mixture was stirred for a further 10 
mins at 0°C. After 10 mins allyl bromide (freshly distilled) (0.15cm3, 1.5mmol) .  
was introduced (in dry DMF). The resultant solution was stirred for 15 mins and 
left to stir at 60°C overnight. After this time, the reaction mixture was cooled to 
room temperature and poured into cold stirred water (30cm3) and extracted with 
ethyl acetate. The combined organic phases were washed with water 10cm3 (x2), 
brine 10cm3 (x2) and dried over magnesium sulfate. Column chromatography 
afforded the title compound as a pale yellow oil (O.lg, 31%), 5h(CDC13); 1.2 (6H, 
d, 7=6.8 ‘Pr), 1.3 (3H, s, Me), 1.5-1.6 (8H, m), 1.9 (1H, m), 2.8 (1H, hept, 7= 6.8, 
‘PrCH), 3.1 (1H, m), 3.5 (1H, m), 3.8 (1H, m), 5.2 (1H, m, CH=CH2), 5.3 (1H, m, 
CHCIfc), 5.8 (1H, m, CH=CH2), 6.5 (1H, d, 7=7.9, Ar-H)), 6.8 (1H, d, 7=1.8, 
Ar-H), 6.9 (1H, dd,7=1.8,7.9 Ar-H), 6c (CDC13); 20.8 (2H), 21.7 (2H), 22.0 (3H),
23.5 (2H), 24.4 (6H), 33.6, 36.1 (2H), 41.9, 49.1 (2H), 70.2, 107.7, 116.2 (2H),
119.1, 124.5, 134.8, 138.4, 139.9, 148.8. m/z (El) % 269.3 (70, M")
Found: m/z (El) 269.213860 C19H27N (M*) requires : 269.214350.
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Attempted preparation of 8-(2-AIlvO-6-isopropvl-l,2,.3,4-tetrahvdro-4a-
methvl-carbazole (43);
To an efficiently stirred solution of the carbazole (42) (0.44g, 1.6mmol) in dry 
DCM (50cm3) at 20°C, a suspension of freshly grpund aluminium trichloride .  
(0.27g, 2.0mmol) in dry DCM (20cm3) was added in small portions. The mixture 
was stirred at room temperature for 20 h under nitrogen before being poured into 
cold water. The mixture was extracted with DCM. The combined organic layers 
were washed with water 15cm3 (x2), brine 15cm3 (x2) and dried over magnesium 
sulfate, however, none of the title compound could be isolated.
Synthesis of l-acetvl-61“methoxv-41.41.81-trimethvlspirorpiperidine-4.21- 
(1,2,3,4-tetrah vd roa u i noline) 1 (50a)
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The amine (86) (0.2g, 0.7mmol) in dichloromethane (10cm3) and acetyl chloride 
(0.06g, 0.05cm3, 0.7mmol) were stirred at room temperature for 20 h in the 
presence of a catalytic amount of DMAP and triethylamine (0.2g, 0.2cm3, 
1.5mmol). The mixture was partitioned between dichloromethane (20cm3) and 
water (20cm3). The organic phase was collected, washed with water 10cm3 (x2),
1%, NaOH 10cm3 (x2), dried over magnesium sulfate and evaporated. The 
residual gum was chromatographed on silica eluting with 30% ethyl acetate in 
petrol to give the title compound as an orange oil (0.18g, 8.0%), 8h (CDCI3); 1.3 
(6H, s, 2x Me), 1.7 (4H, m), 1.8 (2H, s), 2.1 (3H, s, Me), 2.2 (3H, s, Me), 3.5 
(3H, m), 3.8 (3H, s, OMe), 4.1 (1H, m), 6.6 (1H, d, J=2.7, Ar-H), 6.7 (1H, d, 
.7=2.7, Ar-H) ), 8c(CDC13); 17.8 (3H), 21.3 (3H), 32.5, 32.7 (3H), 32.9 (3H), 37.4 .
(2H), 37.7 (2H), 37.9 (2H), 42.7 (2H), 49.0 (2H), 49.6, 55.5 (3H), 110.1 (1H),
113.7 (1H), 123.3, 132.2, 133.7, 151.8, 168.9. m/z (El) % 316.2 (35.0, M*), 301.2 
(10.0, M*-CH3), 273.2 (5.0, Mf-COCHs).
Found: m/z (El) 316.214188 C19H28N2O2 (M*) requires : 316.215078.




The amine (86) (0.24g, 0.9mmol) in dichloromethane (10cm3) and heptanoyl 
chloride (0.19g, 0.2cm3, 0.9mmol) were stirred at room temperature for 20 h in the 
presence of a catalytic amount of DMAP and triethylamine (0.3g, 0.4cm3, 
2.6mmol). The mixture was partitioned between dichloromethane (20cm3) and 
water (20cm3). The organic phase was collected, washed with water 10cm3 (x2), 
1% NaOH 10cm3 (x2), dried over magnesium sulfate and evaporated. The residual 
gum was chromatographed on silica eluting with 30% ethyl acetate in petrol to 
give the title compound as an orange oil (0.09g, 38%), 8h (CDCI3); 0.9 (3H, t, 
J=7.0), 1.3 (12H, m), 1.6 (6H, s, 2x Me), 1.8 (2H, s), 2.2 (3H, s, Me), 2.3 (2H, q, 
.7=7.2, 8.2), 3.4 (3H, m), 3.8 (3H, s, OMe), 3.9 (1H, m), 6.6 (1H, d, .7=2.8, Ar-H),
6.7 (1H, d, .7=2.8, Ar-H), 8c(CDC13); 13.9 (3H), 17.8 (3H), 25.2 (2H), 29.1 (2H),
31.5 (2H), 32.4 (2H), 32.8 (3H), 33.3 (3H) 37.5 (2H), 37.7 (2H), 41.9 (2H), 49.0 
(2H), 49.6 (2H), 49.7, 55.5 (3H), 76.7, 110.1, 113.7, 123.2, 132.1, 133.7, 151.8,
171.6 m/z (El) % 386.4 (20, M+).
Found : m/z (El) 386.293434. C24H38N2O2 flVT) requires : 386.293359.
Synthesis of l-laurovl-61-methoxv-41.41.81-trimethvlspirofpiperidine-4<21- 
(1.2.3.4-tetrahvdroquinoline)] (50c)
( c i y ^
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The amine (86) (0.2g, 0.7mmol) in dichloromethane ( 10cm3) and lauroyl chloride 
(0.16g, 0.2cm3, 0.7mmol) were stirred at room temperature for 6 h in the presence 
of a catalytic amount of DMAP and triethylamine (0.3g, 0.4cm3, 2.2mmol). The 
mixture was partitioned between dichloromethane (20cm3) and water (20cm3).
The organic phase was collected, washed with water 10cm3 (x2), 1% NaOH 10cm3 
(x2), dried and evaporated. The residual gum was chromatographed on silica 
eluting with 30% ethyl acetate in petrol to give the title compound as a yellow oil 
(0.19g, 95%), 6h (CDC13); 0.9 (3H, t, 7=6.8), 1.3 (22H, m) 1.7 (6H, m), 1.8 (2H, 
s), 2.2 (3H, s, Me), 2.3 (2H, t, 7=7.3), 3.5 (3H, m), 3.7 (3H, m), 3.8 (1H, m), 6.7 
(1H, d, 7=2.5 Ar-H), 6.8 (1H, d, 7=2.5 Ar-H), 6C (CDC13); 14.1 (3H), 17.8 (3H),
22.6 (2H), 25.4 (2H), 29.1 (2H), 29.3 (2H), 29.4 (2H), 29.5 (2H), 29.6 (2H), 31.9 .
(2H), 32.5 (2H), 32.8 (3H), 32.9 (3H), 33.4 (2H), 37.5 (2H), 37.8 (2H), 38.1 
(2H), 42.0 (2H), 49.1 (2H), 49.7, 55.6 (3H), 110.3, 113.7, 115.9, 123.2, 132.2, 
133.8, 151.9, 171.7 m/z (FAB) % 456.4 (100, Nf).
Found : m/z (FAB) : 456.3717 C29H48N2O2 (M*+l) requires : 456.3716.




The amine (86) (0.15g, 0.6mmol) in dichloromethane (10cm3) and oleoyl chloride 
(0.16g, 0.2cm3, 0.6mmol) were stirred at room temperature for 6 h in the presence 
of a catalytic amount of DMAP and triethylamine (0.16g, 0.2cm3, 0.6mmol). The 
mixture was partitioned between dichloromethane (20cm3) and water (20cm3).
The organic phase was collected, washed with water 10cm3 (x2), 1% NaOH 10cm3 
(x2), dried with magnesium sulfate and evaporated. The residual gum was 
chromatographed on silica eluting with 30% ethyl acetate in petrol to give the title 
compound as a yellow oil (0.03g, 10%), 8h(CDC13); 0.9 (3H, m, Me), 1.3 (20H, 
m), 1.7 (6H, m), 1.8 (2H, s), 2.0 (4H, m), 2.2 (3H, s, Me), 2.3 (2H, t, J= 7.7), 3.4 
(2H, m), 3.6 (1H, m), 3.8 (3H, s, OMe), 5.4 (2H, m, CH=CH), 6.6 (1H, d, J=2.6, 
Ar-H), 6.7 (1H, d, J= 2.6, Ar-H), 8c (CDC13); 14.1 (3H), 17.9 (3H), 22.7 (2H), #
25.4 (2H), 27.2 (2H), 29.2 (2H), 29.3 (2H), 29.4 (2H), 29.5 (2H), 29.5 (2H), 29.7 
(2H), 29.8 (2H), 31.9 (2H), 32.6 (2H), 32.6 (2H), 32.8 (3H), 32.9 (3H), 33.5 
(2H), 37.5 (2H), 37.9 (2H), 38.1 (2H), 42.0 (2H), 49.1 (2H), 50.0, 55.7 (3H),
110.2, 113.8, 123.3, 129.8, 130.0 130.1, 132.3, 133.8, 151.9, 171.8 m/z (El) %
538.3 (12, M+).





CHjCCCHj^ C H jCO jH
The amine (86) (0.20g, 0.7mmol) in dichloromethane (10cm3) and 3,3- 
dimethylglutaric anhydride (l.Og, 7.0mmol) were stirred at room temperature for 
18 h in the presence of a catalytic amount of DMAP and triethylamine (3.0g, •
4.0cm3, 30mmol). The mixture was partitioned between dichloromethane (20cm3) 
and water (20cm3). The organic phase was collected, washed with water 10cm3 
(x2), dried and evaporated. The residual gum was chromatographed on silica 
eluting with 80% ethyl acetate in petrol to give the title compound as a yellow oil 
(0.3g, 10%) Vmax/cm"1 3408, 1770, 1642cm'1, 6H(CDC13); 1.1 (6H, s, 2xMe), 1.3 
(6H, s, 2x Me), 1,7 (4H, m), 1.8 (2H, s), 2.2 (3H, s, Me), 2.5 (2H, s), 2.5 (2H, s),
3.5 (3H, m), 3.8 (3H, s, OMe), 3.8 (1H, m), 6.6 (1H, d, .7=2.7, Ar-H), 6.7 (1H, d, 
.7=2.7, Ar-H) ), 6c (CDC13); 17.9 (3H), 29.2 (3H), 32.9 (3H), 32.9 (3H), 34.4 
(3H), 38.1 (2H), 38.7 (2H), 40.8 (2H), 43.5 (2H), 47.3 (2H), 49.0 (2H), 49.5 
(2H), 55.6 (3H), 110.2 (1H), 113.9 (1H), 129.6, 132.4, 133.4, 152.1, 171.6,
171.7, 173.1 m/z (El) % 416.1 (38, M+), 274.1 (46, M*-
C0 CH2CH(CH3)2CH2C0 2H).





The amine (86) (0.17g, 0.6mmol) was placed in DCM (10cm3). Linoleic acid 
(0.2cm3, 0.6mmol) and DCC (0.14g, 7.2mmol) were added at 0°C. The reaction 
mixture was left to stir at 0°C for 1 h and allowed to reach room temperature and 
stirred for a further 20 h. Cold ethyl acetate was then added to the solution and 
the resulting solution left to stir in an ice bath for a further 15mins to allow the 
DCU to crystallise out. The solution was then filtered to remove any DCU. The 
residual gum was chromatographed on silica eluting with 30% ethyl acetate in 
petrol to give the title compound as an orange oil (0.05 g, 16%), 8h (CDCI3); 0.9 
(3H, m), 1.4 (20H, m), 1.5 (4H, m), 1.8 (2H, s), 2.0 (3H, s, Me), 2.2 (2H, m), 2.3 
(2H, m), 2.8 (3H, m), 3.4 (3H, m), 3.7 (3H, s, OMe), 3.8 (1H, m), 5.4 (6H, bs, 3x 
CH=CH), 6.6 (1H, d, J= 2.6, Ar-H), 6.7 (1H, d, 7=2.6, Ar-H), 8C (CDC13); 14.1 
(3H), 14.2 (3H), 17.8 (3H), 25.4 (2H), 25.5 (2H), 25.5 (2H), 27.2 (2H), 29.1 
(2H), 29.3 (2H), 29.4 (2H), 29.5 (2H), 29.6 (2H), 32.5 (2H), 32.8 (3H), 32.9 
(3H), 33.4 (2H), 37.8 (2H), 38.1 (2H), 42.0 (2H), 49.1 (2H), 49.7, 55.6 (3H),
135
110.2, 113.7, 123.2, 127.0, 127.7, 128.2, 129.7, 129.9, 130.2, 131.9, 132.2,
133.7, 151.8, 171.6. m/z (FAB) % 534.3 (80,1^).
Found : m/z (FAB) 534.417084 C35H54N2O2 (h/T+1) requires : 534.418529.
The attempted synthesis of the troglitazone analogue (50g)
Compound (96) (0.2g, 0.7mmol) was placed in DMSO (20cm3) with the amine * 
(86) (0.2g, 0.7mmol). Next sodium hydride (0.02g, 0.7mmol) was added. The 
reaction mixture was left to stir at room temperature for 24 h and then stirred at 
reflux for a further 2 h, before quenching with ice water (20cm3). The title 
compound could not be isolated.
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2- Cvclohexvl- 2-phenvl-3. 3. 5. 7-tetramethvlindoline (64a)
To a solution of indolenine (52) (1.5g, 6mmol) in THF (35cm3), sodium metal 
(0.6g, 24.0mmol) was added. The resulting complex was stirred for 4 h then 
chlorocyclohexane (0.7g, 6mmol) was added at -78°C, left at this temperature for 
1 h before allowing to reach to room temperature. The mixture was stirred for 20 
h. It was then treated with saturated ammonium chloride and water, extracted with 
ether 20cm3 (x2) and the combined extracts were dried and evaporated to yield the 
title compound as a colourless oil (0.04g, 2.7%), 6h(CDC13); 0.5 (3H, s, Me), 0.9 
(11H, m), 1.5 (3H, s, Me), 2.2 (3H, s, Me), 2.2 (3H, s, Me), 3.7 (1H, s, NH), 6.6 
(1H, s, Ar-H), 6.7 (1H, s, Ar-H), 7.3 (5H, m, Ar-H), 6c (CDC13); 16.8 (3H), 20.1 
(3H), 21.0 (3H), 26.6 (2H), 27.0 (2H), 28.5 (2H), 30.1 (2H), 31.4 (3H), 34.1,
38.1,46.2, 76.5, 116.0, 118.6, 126.0, 127.8, 128.5, 132.7, 138.1, 144.6, 145.2 m/z 
(El) % 333.2 (10, M*)
Found : m/z (El) 333.245224 C24H31N (M*) requires : 333.2345650.
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3,3«5«7-Tetramethvl-2-(4-cvclohexvlphenvDindoline (65a):
" 0 ^ 0
8h (CDCI3); 1.3 (1H, m), 1.4 (4H, m), 1.5 (6H, s, 2xMe), 1.7 (1H, m), 1.9 (4H, 
m), 2.3 (3H, s, Me), 2.5 (1H, m), 2.6 (3H, s, Me), 6.9 (2H, d, J=1.9, Ar-H), 7.3 
(2H, d, J= 2.0, Ar-H), 8.1 (2H ,, J=2.0, Ar-H), 8C (CDC13); 16.7 (3H), 21.5 (3H), 
24.9 (2H), 26.1 (3H), 26.8 (3H), 34.2 (4H), 44.5 (4H), 53.3, 118.9, 126.9, 128.1,
129.6, 130.0, 131.4, 135.2, 147.7, 149.7, 150.2, 184.0.
3,3.5.6-Tetramethvl-2-phenvlindoline (640
(0.32g, 21%), 8h (CDCI3); 0.7 (3H, s, Me), 1.4 (3H, s, Me), 2.1 (3H, s, Me), 2.3 
(3H, s, Me), 3.8 (1H, bs), 4.5 (1H, s), 6.7 (2H, s, Ar-H), 7.3 (3H, m, Ar-H), 7.5 
(2H, m, Ar-H), 8C (CDC13); 16.6 (3H), 20.9 (3H), 24.4 (3H), 26.6 (3H), 45.5, 
74.6, 118.2, 120.5, 127.3, 127.5, 128.0, 128.3, 128.9, 137.6, 140.2, 145.4.
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2- Benzyl- 2-phenvl-3,3, 5, 7-tetramethvlindoline (64b)
To a solution of indolenine (52) (l.Og, 4.0mmol) in THF (35cm3), sodium metal 
(0.37g, 16.0mmol) was added. The resulting complex was stirred for 4 h then 
benzyl bromide (0.46cm3, 4.0mmol) was added at room temperature. The mixture 
was stirred for 20 h. It was then treated with saturated ammonium chloride and 
water, extracted with ether 20cm3 (x2) and the combined extracts were dried and 
evaporated to yield the title compound as a colourless oil (0.2g, 21.0%), Vmax/cm'1 
3350cm'1, 8h (CDC13); 0.7 (3H, s, Me), 1.3 (3H, s, Me), 2.3 (3H, s, Me), 2.4 (3H, 
s, Me), 4.1 (1H, d, J= 16.9), 4.2 (1H, s, NH), 4.30 (1H, d, >16.9), 6.75 (2H, s, 
Ar-H), 7.2, 10H, m, Ar-H), 8C (CDC13); 19.9 (3H), 20.6 (3H), 26.1 (3H), 28.4 
(3H), 44.1, 51.1 (2H), 78.6, 118.2, 121.1, 126.6, 127.2, 127.5, 127.8, 128.0,
128.2, 128.4, 128.4, 128.5, 129.7, 131.8, 138.8, 139.0, 139.5, 146.0, m/z (El) % 
326 (15, M+-Me), 341.2 (40, M*),
Found: m/z (El) 341.213608 C25H27N (M^ requires : 341.214350.
Also obtained was the indoline (64i) (0.26g, 26 %), formed by reduction of the 
indolenine (52) during the reaction.
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2- Allvl-2-phenvl-3,3,5. 7-tetramethvlindoline (64c)
To a solution of indolenine (52) (l.Og, 4.0mmol) in THF (35cm3) sodium metal 
(0.37g, 16.0mmol) was added. The resulting complex was stirred for 4 h then allyl 
bromide (0.48g, 0.35cm3, 4.0mmol) was added at room temperature. The mixture 
was stirred for 30 h. It was then treated with saturated ammonium chloride and 
water, extracted with ether 20cm3 (x2) and the combined extracts were dried and .  
evaporated to yield a colourless oil of the title compound (O.Olg, 1%), 5h(CDC13);
0.7 (3H, s, Me), 1.4 (3H, s, Me), 2.3 (3H, s, Me), 2.4 (3H, s, Me), 3.4 (1H, s, 
NH), 4.5 (2H, m), 5.0 (2H, m, CH=CH£), 5.8 (1H, m, CHCH2), 6.7 (2H, s, Ar-H),
7.3 (5H, m, Ar-H), 6c (CDC13); 19.8 (3H), 20.7 (3H), 24.9 (3H), 26.2 (3H), 27.2 
(3H), 29.7, 43.8, 50.4 (2H), 78.4, 117.7 (2H), 120.9, 127.3, 128.0, 128.1, 128.4,
128.5, 131.5, 133.7, 138.7, 139.7, 145.4, m/z (El) % 250.1 (20, M+-aUyl), 276.1 
(65, M^-Me), 291.2 (100, M^) and the reduced compound (64i) (0.27g, 27 %), 8h 
(CDC13); 0.7 (3H, s, Me), 1.4 (3H, s, Me), 2.1 (3H, s, Me), 2.3 (3H, s, Me), 3.8 
(1H, bs), 4.5 (1H, s), 6.7 (2H, s, Ar-H), 7.3 (3H, m, Ar-H), 7.5 (2H, m, Ar-H), 
8c(CDC13); 16.6 (3H), 20.9 (3H), 24.4 (3H), 26.6 (3H), 45.5, 74.6, 118.2, 120.5, 
127.3, 127.5, 128.0, 128.3, 128.9, 137.6, 140.2, 145.4, m/z (El) % 276.1 (65, 
M+-Me), 291.2 (100, M+).
Found: m/z (El) 291.198265 C21H25N (M4) requires : 291.198700.
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2- Acetvl- 2-Dhenvl-3, 3 ,5 , 7-tetramethvlindoline (64d)
To a solution of indolenine (52) (1.5g, 6.0mmol) in THF (35cm3) was added, 
sodium metal (0.6g, 24mmol). The resulting complex was stirred for 4 h then 
acetic anhydride (0.6g, 0.6cm3, 6.0mmol) was added at -78°C, left at this 
temperature for 1 h before allowing to reach to room temperature. The mixture 
was stirred for 20 h. It was then treated with saturated ammonium chloride and 
water, extracted with ether 20cm3 (x2) and the combined extracts were dried and 
evaporated to yield the title compound as a brown oil (0.2g, 13%), Vmax/cm'1 
1668cm'1 3346cm'1, 8H(CDC13); 0.9 (3H, s, Me), 1.6 (3H, s, Me), 2.2 (3H, s, Me),
2.3 (3H, s, Me), 2.3 (3H, s, Me), 4.9 (1H, s), 7.2 (2H, s, Ar-H), 7.3 (5H, m, Ar­
il), 8C (CDC13); 20.7 (3H), 21.1 (3H), 22.4 (3H), 23.3 (3H), 24.8 (3H), 31.6 (3H),
46.3 , 77.8, 120.4, 126.7, 126.8, 127.7, 127.7, 128.0, 128.1, 128.2, 128.4, 128.5,
129.7, 130.7, 135.4, 139.1, m/z (El) % 249.1 (52, M'-MeCO), 293.1 (37, IVT). 
Found : m/z (El) 293.1766551 C20H23NO (M+) requires : 293.177965.
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2(3-Methvlbut-2-envO- 2-phenvl-3.3 .5 .7 tetramethvlindoline (640
To a solution of indolenine (52) (l.Og, 4.0mmol) in THF (35cm3) was added 
sodium metal (0.4g, 16.0mmol). The resulting complex was stirred for 4 h then 4 
bromo-2-methylbutene (0.40cm3, 4.0mmol) was added at room temperature. The 
mixture was stirred for 20 h. It was then treated with saturated ammonium 
chloride and water, extracted with ether 20cm3 (x2)* and the combined extracts • 
were dried and evaporated to yield the title compound as a colourless oil (0.0lg, 
1.0%), 8h (CDC13); 0.6 (3H, s, Me), 1.3 (3H, s, Me), 1.4 (3H, s, Me), 1.6 (3H, s, 
Me), 2.3 (3H, s, Me), 2.4 (3H, s, Me), 3.5 (1H, m), 4.2 (2H, d, J=8.1, CH2CH),
5.2 (1H, m, =CH), 6.7 (2H, s, Ar-H), 7.3 (5H, m, Ar-H), 8C (CDC13); 17.9 (3H),
19.8 (3H), 20.7 (3H), 25.6 (3H), 26.2 (3H), 26.9 (3H), 43.7, 45.2 (2H), 78.2,
78.4, 110.4, 119.5, 119.8, 120.8, 127.2, 127.9, 128.1, 128.4, 131.5, 135.2, 138.8,
145.5, 148.4, m/z (El); % 319.3 (97, M+).
Found : m/z (El) 319.229546 C23H29N (M+) requires : 319.230000.
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2-Isopropvl- 2-phenvl-3.3.5. 7-tetramethvlindoIine (64g)
To a solution of indolenine (52) (2.0g, 8.0mmol) in THF (35cm3) was added 
sodium metal (0.7g, 32.0mmol). The resulting complex was stirred for 4 h then 
isopropyl iodide (0.7g, 0.80 cm3, 8.0mmol) was added at room temperature. The 
mixture was stirred for 20 h. It was then treated with saturated ammonium 
chloride and water, extracted with ether 20cm3 (x2) and the combined extracts 
were dried and evaporated to yield the title compound as a colourless powder 
(0.02g, 1.0%), mp: 120-121°C, 8H (CDC13); 0.6 (3H, s, Me), 0.7 (6H, d, .7=6.4 
‘Pr), 1.6 (3H, s, Me), 2.2 (3H, s, Me), 2.2 (3H, s, Me), 2.5 (1H, m, ‘PrCH), 3.7 
(1H, s, NH), 6.6 (1H, s, Ar-H), 6.7 (1H, s, Ar-H), 7.3 (3H, m, Ar-H), 7.6 (2H, 
brs, Ar-H), 8C (CDC13); 16.7 (3H), 19.1 (3H), 19.7 (3H), 20.3 (3H), 20.9 (3H),
31.4, 34.9 (3H), 47.6, 77.6, 116.0, 118.9, 126.0, 127.4, 127.8, 128.5, 138.0, 145.4 
m/z (El) % 293.2 (10, M+).
This product was accompanied by a minute quantity of 2,41-di-isopropyl-2-phenyl-
3,3,5,7-tetramethylindoline.
8h(CDC13); 6.0 (2H, d, J=10.7) 5.9 (2H, d, J=10.7).
Found: m/z (El) 293.213348 C2iH27N (M") requires : 293.214350.
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The preparation of iV-(2-methvlbenzvlidene)-2“bromoaniline (66)
Br
p-Tolualdehyde (3.0g, 3.1cm3, 25.0mmol) and 2 bromoaniline (3.4g, 25.0mmol) 
were reacted together under Dean-Stark conditions using toluene (35cm3) as 
solvent and a few p-toluenesulfonic acid crystals. The solvent was evaporated to 
afford the title compound as a green oil (5.0g, 73%), vmax/cm'11606 cm'1, 5h 
(CDC13); 2.4 (3H, s, Me), 7.0 (2H, m), 7.3 (3H, m), 7.6 (1H, d, J= 7.3), 7.8 (1H, d, 
.7=8.1), 7.8 (1H, d, .7=7.9), 8.3 (1H, s, CH=N), 6C (CDC13); 21.6 (3H), 119.8,
126.4, 128.3, 129.5, 129.6, 129.7, 132.5, 132.9, 133.3, 142.2, 150.9, 161.5, 
191.9; m/z (El) % 274.0, 276.1 (55, 55, M+).
Attempted preparation of 5 ,6-dihvdrophenanthridine (671
Method 1
The imine (66) (l.Og, 3.7mmol) was placed in THF (35cm3) and sodium metal 
(0.084g, 3.7mmol) was then added. The resulting complex was left to stir for 20 h
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and then it was treated with saturated ammonium chloride solution and water, 
extracted with ether 10cm3 (x2) and the combined extracts dried and evaporated. 
Unfortuantely no single product was isolated.
Method 2
The imine (66) (l.Og, 3.6mmol) was placed in THF (35cm3). Sodium metal (0.3g, 
14.6mmol) was added and the mixture stirred for 4 h. The resulting solution was 
decanted from the excess sodium, placed in a flask and left on a sonic bath for 6 h. 
It was then treated with saturated ammonium chloride solution and water, 
extracted with ether 15 cm3 (x2) and the combined extracts dried and evaporated. 
Once again no products could be isolated.
jV-Benzvlidene-3-bromopropvlamine (77)
A solution of benzaldehyde (1.4cm3, lO.Ommol) in dichloromethane (35cm3) was 
treated with triethylamine (1.9cm3, lO.Ommol), 3 bromopropylamine hydrobromide 
(3.1g, lO.Ommol) and magnesium sulfate (2.0g). The mixture was stirred under 
reflux for 30 mins. After cooling, the drying agent was filtered off and the solvent 
evaporated off in vacuo. After the addition of dry ether (15cm3), the colourless 
precipitate was filtered and washed with dry ether. The filtrate was evaporated to 
give a pale yellow oil (1.75g, 77%), Vmax/cm'11646cm*1, 5h (CDCI3); 2.2 (2H, m),
3.5 (2H, t, .7=6.4), 3.7 (2H, t, J= 6.3), 7.3 (3H, m, Ar-H), 7.7 (2H, m, Ar-H), 8.3
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(1H, s, CH=N), 8c (CDCb); 31.6 (2H), 33.2 (2H), 58.7 (2H), 128.0, 128.5, 130.7,
132.6, 135.9, 162.0 m/z (El) % 229.1/227.9 ( 100, 100, IVT).
Found : m/z (El) 227.013287/229.01330 CioH^NBr (M+) requires : 
227.013264/229.0132.
Synthesis of l-tert-butoxvcarbonvl-4-(4methoxv-2methvlanilinolpiperidine 
(831
Boc
4-Methoxy-2-methylaniline (2.6cm3, 0.02mol) was mixed with iV-fer/-butoxy- 
carbonyl-4-piperidone (4.0g, 0.02mol) in toluene (50cm3). The solution was then 
refluxed for 4 h under Dean-Stark conditions in the presence of a few crystals of 
toluene-4-sulphonic acid. The solvent was then removed from the mixture and the 
product used directly in the next step; Vn /^cm*1= 1698cm'1 (C=N).
Preparation of 2-methvlallvllithium
Lithium sand (0.14g, 0.02mol) was added in dry ether at 0°C into a 3 necked 
round bottom flask in the presence of argon. 3 Bromo-2-methyl-prop-2-ene (2.0g,
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1.4cm3, 0.015mol) in ether was then added. The reaction was then left to warm up 
to room temperature and stirred at this temperature for a further 30 h before using 
directly in the next reaction. To check the formation of the Grignard a small 
aliquot was taken and quenched with benzaldehyde. Column chromatography 




Sh(CDC13); 1.82 (3H, s, Me), 2.17 (1H, m), 2.4 (2H, m), 4.9 (3H, m), 7.3 (5H, m, 
Ar-H), 8C (CDC13); 22.3 (3H), 48.3 (2H), 71.3, 114.0 (2H), 125.73 (2x 1H),
127.5, 128.4 (2x 1H). m/z (FAB) % 165.1 (15, M"+l).
Preparation of 2-methvlallvlmagnesium bromide*^
MgBr
Magnesium turnings (0.72g, 0.03mol) were placed in a round bottom flask and 
stirred vigorously under argon for 24 h. Anhydrous ether (10cm3) was then added 
before placing a small iodine crystal in the solution. 3-Bromo-2-methylprop-2-ene 
(4.0g, 3.0cm3, 0.03mol) in ether (2.0cm3) was then added dropwise at room
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temperature under argon. The resulting solution was then stirred for an additional 
hour before using directly in the next reaction. To check the formation of the 
Grignard a small aliquot was taken and quenched with benzaldehyde. Column 
chromatography eluting with 10% ethyl acetate in petrol yielded the alcohol (87).




The organolithium reagent made in the previous reaction was added to the imine 
(83) (7.5g, 0.02mol) and the reaction mixture was left to stir for 6 h at room 
temperature. The reaction mixture was then quenched with saturated ammonium, 
chloride, and the phases were separated. The organic phase was washed with 
water 25cm3 (x2), and dried using magnesium sulphate. The solvent was then 
removed under vacuum. Column chromatography was unrewarding.
Method 2
The organomagnesium reagent made in the previous reaction was added to the 
imine (83) (7.5g, 0.02mol) and the reaction mixture was left to stir for 6 h at room 
temperature. The reaction mixture was then quenched with saturated ammonium, 
chloride, and the phases were separated. The organic phase was washed with
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water 25cm3 (x2), and dried using magnesium sulphate. The solvent was then 
removed under vacuum. Column chromatography was unsuccessful.
Method 3
Imine (83) (3.18g, lOmmol) was added dropwise to the organolithium reagent 
(0.6g, lOmmol) prepared as above. Zinc chloride (10cm3, 1.0M solution) was then 
added. The reaction mixture was then stirred for a further 30 h. TLC indicated 
that no product had been formed.
Method 4
Cerium(III) chloride heptahydrate (14.9g, 40mmol) was crushed in a mortar and 
placed in a flask. The flask was immersed in an oil bath and heated gradually to 
135-140°C with evacuation. After maintaining constant temperature for an hour a 
magnetic stirrer was added and the cerium chloride completely dried in vacuo 
whilst stirring at the same temperature for a further hour.
While the flask was still hot, argon gas was introduced and the flask cooled in an 
ice bath. Cold THF was added whilst stirring vigorously. The ice bath was 
removed and the suspension was well stirred at room temperature overnight under 
argon. After this time the flask was immersed in ice and the organolithium was 
added (2.5g, 40mmol). After stirring for 1.5 h at 0°C the imine (83) (12.7g, 
40mmol) was added dropwise. The reaction mixture was further stirred overnight. 
TLC indicated the absence of the desired product.
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Synthesis of l-tert-butoxvcarbonvI-4-(4-methoxv-2methvIphenvIaminol-4-(2- 
methvlpron-2-envl)niperidine (85)
Sodium enriched lithium sand (0.6g, 0.08mol) was added to pentane (50cm3) under 
an atmosphere of argon gas. 3-chloro-2-methylprop-2-ene (5.4g, 6.0cm3, 
0.06mol) was added to this. The imine (83) (12.0g) formed previously dissolved • 
in THF (15cm3) was then added slowly, and the reaction was left to stir for 30 h 
under argon. The reaction mixture was quenched with saturated aqueous 
ammonium chloride, and the phases were separated. The organic phase was 
washed with water 25cm3 (x2), and dried using magnesium sulphate. The solvent 
was then removed under vacuum, and the remaining oil purified by 
chromatography, eluting with 4% ethyl acetate in petrol to give the title compound 
(2.32g, 31%), 8h(CDC13); 1.5 (9H, s, *Bu), 1.7 (3H, s, Me), 2.0 (4H, m), 2.1 (3H, 
s, Me), 2.5 (2H, s), 3.1 (4H, m), 3.7 (3H, s, OMe), 4.6 (1H, s), 4.9 (1H, s), 6.7 
(3H, m, Ar-H), 6C (CDC13); 18.1 (3H), 24.6 (3H), 28.0 (9H), 35.1 (4H), 39.1 
(2H), 45.4 (4H), 53.7, 545.0 (3H), 78.9, 110.8, 114.7, 116.8, 125.2, 137.3, 141.4,
151.2, 154.3. m/z (El) % 319.1 (55, M+-CH2(=CH2)CH3), 374 (15, M*).
Found : m/z (El) 374.25646 C22H34N20 3 (M+) requires : 374.256943.
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and the side product (84)
(0.5g), SH (CDCb); 1.8 (3H, s, Me), 2.2 (3H, s, Me), 3.7 (2H, s), 3.7 (3H, s, 
OMe), 4.9 (1H, s), 5.0 (1H, s), 6.5 (1H, d, J= 8, Ar-H), 6.6 (2H, m, Ar-H), 6C 
(CDCI3); 17.6 (3H), 20.5 (3H), 50.5 (2H), 55.6 (3H), 110.6 (2H), 111.0, 111.4,
116.8, 123.5, 140.3, 143.0, 151.5, m/z (El) % 136.0 (100, M* - CH2(=CH2)CH3), 
176.1 (17, M* - CH3), 191.1 (73, M*).
Synthesis of 61-methoxv-41,41 ^S^trimethylspirorpiperidine^^Wl.l^^- 
tetrahydroquinolinell (86, R=OMe)
H
Concentrated sulfuric acid (5cm3) was added slowly to the amine (85) (0.5g, 
1.6mmol) formed in the previous experiment in an ice bath, and the reaction 
mixture was warmed to for about 5 mins. Ice (9.0g) was added and the mixture 
basified with 6M ammonium hydroxide. The solution was then extracted three 
times with ethyl acetate, and the organic phases were combined, dried with 
magnesium sulfate, and evaporated. The crude product consisted of a mixture of
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the required spiro compound and its O-Methyl derivative in the ratio of 4:3. These 
two compounds were separated by chromatography.
(86, R = OMe), /cm'13415cm'1 and 3300cm'1,8 H (CDCI3); 1.3 (6H, s, 2xMe),
1.6 (4H, m), 1.8 (2H, s), 2.2 (3H, s, Me), 2.5 (1H, brs, exchangeable), 2.9 (4H,
m), 3.7 (1H, brs, exchangeable), 3.8 (3H, s, OMe), 6.5 (1H, d, 7= 3, Ar-H), 6.7
(1H, d, 7= 3, Ar-H), 6c (CDCl3); 17.5 (3H), 31.2 (3H), 32.2 (3H), 32.7 (3H), 38.4 
(2H), 40.8 (2H), 41.8 (2H), 42.3 (2H), 49.4 (2H), 55.3 (3H), 57.5, 111.3, 113.3,
122.5, 124.8, 131.80, 134.0, 151.2 m/z (El) % 274.1 (75, M+).
(Found : m/z (El) 274.2046 C17H26N2O (M*) requires : 274.2045.
(86, R = OH), Vmax /cm*13470-3300cm_1, 6H (CDC13); 1.3 (6H, s, 2xMe), 1.6 (4H, 
m), 1.7 (2H, s), 2.1 (3H, s, Me), 2.5 (1H, brs, exchangeable), 2.88 (4H, m), 3.6 
(1H, brs, exchangeable), 6.4 (1H, d, 7=2.5, Ar-H), 6.6 (1H, d, 7=2.5, Ar-H), 8C 
(CDCI3); m/z (El) % 260.1 ( 10, M+).
Found: m/z (El) 260.1870 C16H24N2O (MT) requires : 260.1889.
Synthesis of 5-(4-acetoxvbenzvlidenelthiazolidine-2,4-dione (981
NH
MeOX
Methyl 4-formylbenzoate (1.8g, ll.Ommol), (13g, ll.Ommol) 2,4 
thiazolidinedione (1.3g, ll.Ommol), piperidine (0.2cm3) and glacial acetic acid 
0.02cm3 were placed in toluene and the solution was refluxed for 2 h. The solution
was left to cool in a fridge overnight, then filtered with cold ether yielding the title 
compound (2.5g, 89%) as a white powder. Mp: 200-201°C, 5h(CDC13); 3.0 (3H, 
s, OMe) 6.8 (2H, d, 7=8.4, Ar-H) 6.9 (1H, s, C=CH) 7.2 (2H, d, 7=8.4, Ar-H), 
5c(CDC13); 50.8 (3H), 125.0, 128.4 (2H), 128.4 (2H), 128.9, 129.1, 135.9, 164.3,
166.2, 166.4. m/z (El) % 263.0 (45, M*).
Found: m/z (El) 263.025230 C12H9NO4S (M*) requires : 263.02576.
Synthesis of 5-(4-acetoxvbenzvnthiazolidine-2,4-dione (991
MeOX
Compound (98) (2.0g, 7.7mmol) placed in dioxane (20cm3), 10% palladium on 
carbon (4.0g) was added and the resulting solution hydrogenated until hydrogen 
uptake ceased. The title compound (1.46g, 72%) was obtained as a colourless oil 
vmax 1700cm*1, SH (CDCI3); 3.2 (1H, m), 3.5 (1H, dd, 7=4.4, 4.4), 3.9 (3H, s, 
OMe), 4.7 (1H, m, CHCH2), 7.4 (2H, d, 7= 8.4, Ar-H), 7.9 (2H, d, 7=8.4, Ar-H),
9.0 (1H, brs), 8C (CDC13); 36.4 (2H), 50.6 (1H), 51.0 (3H), 127.3, 127.9 (2H),
128.0 (2H), 140.6, 164.7, 170.1, 174.3. m/z (FAB) % 264.01 (40, M++l).





A solution of 4-formylbenzoic acid (1.5g, lOmmol), DCC (2.3g, lOmmol), benzyl 
alcohol (1.2g, 1.1cm3, lOmmol) and 4-pyrrolidinopyridine (0.15g, l.Ommol) in 
dichloromethane (40cm3) was allowed to stand at room temperature until 
esterification was complete. The DCU was filtered off and the filtrate washed with 
water, 5% acetic acid and again with water, dried with magnesium sulfate and the 
solvent evaporated in vacuo. The title compound (0.25g, 10%), mp: 141°C was 
obtained as a colourless solid by crystallisation from hexane in DCM.
Method 2
The carboxylic acid (0.75g, 5.0mmol) and sodium hydrogen carbonate (0.7g, 
8.3mmol) were placed in DMF (25cm3). Benzyl bromide (0.7g, 0.5cm3, 4.2mmol) 
was then added dropwise at room temperature. The reaction mixture was left to 
stir overnight, and then diethyl ether was added (20cm3). The solution was washed 
with water 5cm3 (x2), saturated sodium hydrogen carbonate 5cm3 (x2) and dried 
over magnesium sulfate. The organic phases were combined and evaporated to 
afford an oil, which was chromatographed on silica gel, eluting with 20% ethyl
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acetate in petrol to afford the title compound (0.3g, 28%), mp: 141°C c.f. lit 142- 
144°C, 8h (CDCI3); 5.4 (2H, s), 7.4(5H, m), 8.0 (2H, d, J= 8.2), 8.2 (2H, d, 
J= 8.2), 10.1 (1H, s), 8C (CDCI3); 67.3 (2H), 128.3, 128.5, 128.7, 129.5, 130.3, 
135.0, 135.5, 139.2, 191.6. m/z (El) % 240.2 (40, M*).
Found : m/z (El) 240.078659, Ci5Hi20 3(M+) requires : 240.078644.





Benzyl 4-formylbenzoate (3.0g, 12.5mmol), 2,4-thiazolidinedione (1.46g,
12.5mmol), piperidine (0.3cm3) and glacial acetic acid (0.03cm3) were placed in 
toluene (25cm3) and the solution was refluxed for 2 h under Dean-Stark 
conditions. The solution was placed in the fridge overnight and filtered with cold 
ether solution. None of the title compound could be isolated.
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Method 2
Benzyl 4-formylbenzoate (0.5g, 2.2mmol) was placed in DCM with sodium 
hydroxide (0.09g, 2.2mmol) in a small amount of water. Thiazolidine-2,4-dione 
(0.27g, 2.2mmol) was then added. The reaction mixture was stirred at room 
temperature for 16 h before quenching with water and extracting with DCM. 
However, starting material was isolated after column chromatography.
Method 3
Thiazolidine-2,4-dione (0.27g, 2.2mmol) and sodium hydride (O.lg, 4mmol) were 
placed in DCM and stirred under nitrogen for a few mins. Benzyl 4- 
formylbenzoate (0.5g, 2.2mmol) was then added portionwise. The resulting 
solution was left to stir overnight. Again only starting material was isolated after 
column chromatography.




The ester (99) (0.5g, 1.9mmol) was dissolved in water and taken up in 2M sodium 
hydroxide solution. The reaction mixture was left to stir at 60°C for 3 h. The 
reaction mixture was then cooled with ice and concentrated hydrochloric acid was 
added dropwise. Ethyl acetate (15cm3) was added. The solution was washed with
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water 10cm3 (x2) and dried over magnesium sulfate. The organic phase was 
evaporated to afford an oil.
Method 2
Compound (99) (0.28g, 1.2mmol) was placed in acetonitrile (20cm3), 
Trimethylsilyl iodide (0.47g, 0.30cm3, 2.4mmol) was then added. The resulting 
solution was stirred for 30 h at reflux, before quenching with water. The title 
compound could not be isolated.
General procedure for enzyme hydrolysis of 5-(4-acetoxvbenzv0thiazolidine-
2.4-dione (1061
The substrate was suspended in water and the enzyme was added. The solution 
was stirred between 25-40°C (depending on the enzyme) for 1 week. The enzyme 
was removed by filtration and the aqueous layer extracted with ethyl actete and 
concentrated in vacuo.
l«2-Diamino-4«5-dimethvlbenzene (108)99
4,5-Dimethyl-2-nitroaniline (1.7g, O.Olmol) in ethanol (100cm3) was stirred under 
hydrogen in the presence of 10% Pd on carbon (0.18g) as catalyst for 16 h. The
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catalyst was then removed by filtration and the filtrate evaporated to yield the title 
compound (1.3g, 93%) as a colourless solid mp: 125-127°C cf lit 125-126°C, 5h 
(CDCI3); 2.1 (6H, s, 2x Me), 3.1 (4H, s, 2x NH2), 6.5 (2H, s, 2x Ar-H) 6C 
(CDCI3); 18.8 (6H), 118.5, 127.8, 132.2. m/z (El) % 136.1 (100, M+).
Found: m/z (El) : 136.100578, CsH^Nz (M*) requires : 136.100048.
l-f4-(7V-fe/f-ButoxvcarbonvDpiperidenvleneaminol-2-aminobenzene (1101
1,2-Phenylenediamine (l.lg , lO.Ommol) was mixed with Af-fert-butoxy-carbonyl-4- 
piperidone (2.0g, lO.Ommol) in toluene (50cm3). The solution was then refluxed 
for 16 h under Dean-Stark conditions. The solvent was then removed from the 
mixture and the title compound isolated Vmax/cm'1 1681cm'1 (C=N)
Spiro[/V-fert-butoxvcarbonvlpyridine-4,21-benzimidazolel (111, R=H1
A hot solution of 1,2-phenylenediamine (0.5g, 5.0mmol) was prepared by boiling 
an aqueous solution of the diamine with activated charcoal for a few mins followed 




causing the formation of a heavy white precipitate in mins. The mixture was 
heated for a further 10 mins, cooled and the precipitate filtered off. It was washed 
with hot water and recrystallised from ethanol. The title compound was obtained 
as a white powder (l.Og, 67%) mp: 105-108 °C, 8H(CDC13); 1.0 (9H, s, *Bu), 1.4
m, Ar-H), 8c (CDC13); 28.0 (9H), 38.1 (4H), 40.7 (4H), 76.5, 79.3, 109.3 (2H), 
119.6 (2H), 139.2, 154.3. m/z (FAB) % 289.3 (100, IVT+l).
Found: m/z (FAB) 289.179039 C ieH ^O z  (IVf+l) requires : 289.179027.
SpirofA-fe/t“butoxvcarbonvlpvridine-4<21-(4<6-dimethvlbenzimidazolell (111. 
R=Mel
A hot solution of 4,5-dimethylbenzene-1,2-diamine (0.3g, 2.5mmol) was prepared 
by boiling an aqueous solution of the diamine with activated charcoal for a few 
mins followed by filtration. N-Boc piperidone (0.5g, 2.7mmol) was added with 
vigorous shaking causing the formation of a heavy white precipitate in mins. The 
mixture was heated for a further 10 mins, cooled and the precipitate filtered off. 
The title compound was obtained as an unstable yellow solid (0.18g, 26%), 5h
(4H, t, 7= 5.9), 3.1 (4H, t, 7= 5.9), 4.4, (2H, s, 2x NH), 6.1 (2H, m, Ar-H), 6.2 (2H,
NBoc
(CDC13); 1.5 (9H, s, lBu), 1.8 (4H, t, 7=5.7), 2.1 (6H, s, 2x Me), 3.5 (4H, t,
7=5.7), 4.8 (2H, brs, 2xNH), 6.4 (2H, s, Ar-H), 8c (CDCl3); 21.3 (6H), 28.4 (9H),
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32.0 (4H), 41.2 (4H), 79.8, 80.0, 104.5, 122.3 (2H), 147.0, 154.7, 155.0, 160.2. 




A hot solution of 1,2-phenylenediamine (0.5g, 5.0mmol) was prepared by boiling 
an aqueous solution of the diamine with activated charcoal for a few mins followed 
by filtration. Cyclohexanone (0.52cm3, 5.2mmol) was added with vigorous 
shaking causing the formation of a heavy white precipitate in mins. The mixture 
was heated for a further 10 mins, cooled and the precipitate filtered off. It was 
washed with hot water and recrystallised from ethanol. The title compound was 
obtained as yellow needle crystals (0.62g, 66%) mp:134-135°C, c.f. lit 130°C, Sh 
(CDC13); 1.4 (10H, m), 3.6 (2H, s, 2x NH), 6.4 (2H, m, Ar-H), 6.4 (2H, m, Ar-H), 
8C (CDCI3); 23.5 (4H), 25.4 (2H), 39.4 (4H), 80.1, 110.2, 120.5, 140.0. m/z (El) 





A hot solution of 4,5-dimethylbenzene-1,2-diamine (0.9g, 6.7mmol) was prepared 
by boiling an aqueous solution of the diamine with activated charcoal for a few
added with vigorous shaking causing the formation of a heavy white precipitate in 
mins. The mixture was heated for a further 10 mins, cooled and the precipitate 
filtered off. The title compound was obtained as a brown solid (1.35g, 78%), 8h 
(CDC13); 1.8 (4H, m), 2.1 (6H, s, Me), 2.1 (3H, s, Me), 3.5 (4H, m), 3.9 (2H, brs),
6.4 (2H, s, Ar-H). m/z (FAB) % 258.2 (100, JVT+1).
Found: m/z (FAB) 258.160576, C15H20N3O (M*+l) requires : 258.160637.
l,2-Di-rZV-(Ar-4-ferf-butoxvcarbonvlelvcino0aminol4.5-dimethvIbenzene (1191
l,2-Diamino-4,5-dimethylbenzene (0.5g, 3.7mmol) was added to A-Boc glycine 
(1.4g, 8.1mmol) and HOBt (1.2g, 9.2mmol) in DCM. The resulting solution was 
cooled to 0°C before the addition of DCC (10cm3 1M solution in DCM). The 
solution was left to reach room temperature and then allowed to stir for a further 
16 h. The reaction mixture was quenched with water and extracted with ethyl 
acetate 5cm3 (x2). The organic layers were combined, dried. The organic layers 
were combined and evaporated to afford an oil. This was chromatographed on
mins followed by filtration. A-Acetyl-piperidone (l.Og, 0.7cm3, 7.0mmol) was
H O
N ^ N B oc
■n ^ K ^ NBoc
H O
Method 1
silica gel eluting with 50% ethyl acetate in petrol to yield the title compound as a 
colourless solid (0.3g, 22%).
Method 2
l,2-Diamino-4,5-dimethylbenzene (0.5g, 3.7mmol) and N-Boc glycine (1.9g,
EDC (2.3g, 12mmol) was then added portionwise and the resulting solution was 
left to stir overnight. The volume of DCM was reduced and ethyl acetate was 
added. The solution was separated with potassium hydrogen sulphate 10cm3 (x2), 
sodium hydrogen carbonate 10cm3 (x2), sodium hydroxide 10cm3 (x2), and finally 
brine 10cm3 (x2). The organic layers were combined and evaporated to afford an 
oil which was chromatographed on silica gel eluting with 50% ethyl acetate in 
petrol to yield the title compound as a colourless solid (1.2g, 70%) mp: 115.5-
5.9 (2H, s, 2x NHBoc), 7.1 (2H, s, 2x Ar-H), 8.6 (2H, s, 2x CONH), 5C (CDC13); 
19.2 (6H), 28.4 (18H), 44.4 (4H), 80.1, 127.0 (2H), 127.7, 135.0, 156.4, 169.3. 
m/z (El) % 450.3 (15, M+).
Found: m/z (El) 450.248352 C22H34N4O6 (M*) requires : 450.247835.
l,2-DiMV-glvcinovnaminol-4,5-dimethvlbenzene (1201
11 mmol) were placed in DCM (50cm3) and stirred for a few mins under nitrogen.




To a solution of compound (119) (1.2g, 2.6mmol) in DCM was slowly added a 
solution of 50% trifluroacetic acid in DCM (25cm3). The resulting solution was 
then stirred at room temperature until no more carbon dioxide was given off. The 
title compound was obtained as a powder (0.28g, 44%) mp: 203-204 °C, 8h  
(DMSO); 2.2 (6H, s, 2x Me), 3.8 (4H, s, 2x CH2), 7.3 (2H, s, 2x Ar-H), 8.3 (4H, 
s, 2xNH2), 9.8 (2H, s, 2x NHCO), 8c (DMSO); 19.2 (6H), 41.1 (4H), 126.0 (2H), 
127.7, 133.9, 165.4. m/z (FAB) % 251.2 (100, M"+l).
Found: m/z (FAB) 251.151134 C12H19N4O2 (M++1) requires : 251.150801.





l,2-Di-(/V-glycinoyl)amino-4,5-dimethylbenzene (120) (0.9g, 4.1mmol) was added 
to a stirred suspension of lithium aluminium hydride (0.6g, 16.5mmol) in THF 
(20cm3) at 0 °C. The resulting solution was left to stir at reflux for 2-3 h, cooled 
and then left to stand overnight. The reaction mixture was then treated with 20% 
solution of sodium hydroxide to afford a dark yellow oil. Chromatographic 





To a mixture of l,2-di-(Ar-glycinoyl)amino-4,5-dimethylbenzene (120) (0.5g, 
2.0mmol) and 0.2mol% carbonyltris(triphenylphosphine)rhodium(I)hydride 
(0.0037g) in THF (2cm3) was added diphenylsilane (0.9cm3, 9.6mmol) at room 
temperature. After 24 h, the reaction mixture was diluted with diethylether and 
extracted with 1M HC1. The aqueous layer was basified with 15% sodium 
hydroxide solution and extracted with ethylacetate. The organic layer was dried 
over sodium sulfate and concentrated under reduced pressure to afford starting 
material.
Method 3
A solution of borane complex (8cm3, 8.0mmol) (1M in THF) was placed in a flask 
under argon and cooled to 0°C. l,2-Di-(7vr-glycinoyl)amino-4,5-dimethylbenzene 
(120) (0.5g in THF 25cm3) was then added over a 15 minute period. The resulting 
solution was refluxed for 16 h before addition of 2M HC1 solution (4.5cm3) slowly. 
The THF was removed under reduced pressure, then the reaction mixture was 
neutralised with sodium hydroxide before extracting with diethyl ether. Only 







Ethanolamine (2.5g, 2.4cm3, 40mmol) was placed in DCM and stirred in the 
presence of triethylamine (2.0g, 2.8cm3, 20mmol) for a few mins. Lauroyl chloride 
(4.4g, 4.6cm3, 20mmol) was then added dropwise. The resulting solution was left 
to stir overnight, and then quenched with water. The organic product was taken 
up into DCM (20cm3), washed with water 5cm3 (x2), sodium hydrogen carbonate 
5cm3 (x2), brine 5cm3 (x2), dried over magnesium sulfate and evaporated to afford 
the title compound as a colourless solid (6.8g, 70%) mp: 80-82°C, 8h(CDC13); 0.9 
(3H, t, .7=6.5), 1.3 (16H, brs), 1.6 (2H, m), 2.2 (2H, m), 3.4 (2H, t, 7=4.8, 
CHzNH), 3.6 (1H, brs, OH), 3.7 (2H, t, 7=4.9), 6.4 (1H, brs, NHCO), 8C(CDC13);
14.1 (3H), 22.6 (2H), 25.7 (2H), 29.3 (8H), 29.3 (2H), 29.5 (2H), 29.6 (2H), 31.9 
(2H), 36.6 (2H), 42.4 (2H), 46.0 (2H), 62.1 (2H), 174.6. m/z (FAB) % 244.3 
(100, MT+1).
Found : C, 68.7; H 12.1; N, 5.83. C14H29NO29 requires : C, 69.09; H, 12.01; N, 
5.75.
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Attempted preparation ofTV-dodecanoylaminoacetaldehvde (128)
q (CHj) 10CH3 
O
Method 1
PCC (6.9g, 32mmol) was dissolved in DCM (25cm3). JV-Dodecanoylaminoethanol 
(127) (5.1g, 21mmol) was dissolved in a small amount of DCM and added to the 
reaction mixture in one portion. The resulting solution was stirred at room 
temperature for 1.5 h. The reaction mixture was diluted with diethyl ether 
(25cm3). The supernatant liquid was decanted off from the black gum. The black • 
residue was washed thoroughly with portions of warm ether. The organic layer 
and ether washings were combined and filtered through a pad of fluorosil. The 
filtrate was evaporated to afford the dodecanoic acid as an oil 
Vmax/cm*1 = 3302cm'1.
Method 2
A solution of DCM (25 cm3) and oxalyl chloride (1.0cm3, 1 l.Ommol) was placed in 
a 3 necked flask fitted with a calcium sulfate drying tube and 2 dropping funnels.
One of the funnels contained dimethylsulfoxide (1.7cm3, 22.0mmol) dissolved in 
DCM (5cm3) and the other contained vV-Dodecanoylaminoethanol (127) (2.4g, 
lO.Ommol) dissolved in DCM 10cm3). The dimethyl sulfoxide solution was added 
to the stirred oxalyl chloride solution at -50°C. The reaction mixture was stirred 
for 2 mins and the alcohol was added over 5 mins, stirring continued for a further
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15 mins after which triethylamine (7.0cm3, 50.0mmol) was added and the reaction 
mixture stirred for 5 mins before being allowed to reach room temperature. JR 
spectroscopy indicated the formation of dodecanoic acid Vmax/cm'1 = 3302cm*1.
Attempted preparation of (129)
H H O  
- Y ^ i/ n \ / n ^ ( c h 2)10c h 3
A flask was charged with aldehyde (128) (0.3g, 1.4mmol) and the diamine (108) 
(0. lg, 0.7mmol), anhydrous sodium acetate (0.2g, 2.7mmol), freshly activated 4 A 
molecular sieves (1.4g) in absolute methanol (20 cm3). The sodium 
cyanoborohydride (0.17g, 2.7mmol) was added in a single portion, and the reaction 
was stirred at room temperature overnight. Excess 10% aqueous hydrochloric 
acid was added to carefully adjust to pH=2 to destroy excess sodium 
cyanoborohydride. The aqueous layer was adjusted to pH=10 with saturated 
sodium carbonate solution and extracted with ethyl acetate 10cm3 (x2). The 
combined organic layers were washed with brine 10cm3 (x2), dried with 
magnesium sulfate and concentrated in vacuo. The title compound was not 
isolated after column chromatography.
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Attempted preparation of l-flV-dodecanovlamino)-2-bromoethane (130)
^^(C H j) 10CH3 
O
Method 1
Triphenyl phosphine (1.6g, 6.2mmol), bromine (0.9g, 0.3cm3,5.7mmol) and 
imidazole (0.5g, 6.6mmol) were mixed together in dry DCM at 0°C under 
nitrogen. The suspension was stirred for 30 mins at 0°C. N- 
Dodecanoylaminoethanol (127) (l.Og, 4. lmmol) dissolved in DCM was then added 
dropwise. The solution was then stirred for a further 2 h before being poured into 
saturated sodium thiosulfate. The reaction mixture was extracted with DCM 
10cm3 (x2), dried with magnesium sulfate and evaporated at reduced pressure. 
Only triphenyl phosphine was isolated after chromatography of the oily product.
Method 2
To a solution A-dodecanoylaminoethanol (127) (1.5g, 6.2mmol) in 75cm3 
diethylether at 0°C was added phosphorus tribromide (1.7g, 0.6cm3, 6.2mmol) 
freshly distilled. The reaction mixture was left to stand at room temperature for a 
further 24 h before being used directly in the proceeding experiment. It should be 
noted that on washing this bromo compound even with ice briefly resulted in the 
formation of the alcohol.
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Experimental to Electrochemistry section
A-Benzalaniline (68)53
PhCH=NPh
Benzaldehyde (3.2g, 3.1cm3, 30mmol) and aniline (2.8g, 2.7cm3, 30mmol) in DCM 
were left to stir in the presence of 4A molecular sieves over the weekend. The 
solvent was removed and the residue washed with dry chloroform 10cm3 (x2).
The title compound was obtained as yellow crystals (4.3g, 79%), mp: 49-51°C cf 
lit value 50°C, W c m '1 = 1640cm'1 (C=N), SH (CDC13); 7.2-7.3 (3H, m, Ar-H), •
7.5 (5H, m, Ar-H), 7.9 (2H, m, Ar-H), 8.5 (1H, s, CH=N), 8C (CDC13); 120.8, 
125.9, 128.7, 128.8, 129.0, 129.1, 129.7, 131.3, 136.2, 152.0, 160.3. m/z (El) %
180.1 (M*).
General Electrolysis Procedure
The initial setup used a conventional 2 compartment H-type cell where a pool of 
mercury or a platinum gauze (4cm2) (previously cleaned in concentrated nitric 
acid) served as the cathode and either silver or platinum was chosen for the anode.
The solvent was generally DMF, although acetonitrile was used on a few occasions 
and the supporting electrolyte was tetrabutylammoniumhexaflurophospate 
(TBAHFP) (0.1M).
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Since the potential for the reductions were close to the decomposition potential of 
the solvent and electrolyte, attempts were made to control the cathode potential 
using a 3 electrode arrangement where a rotating disc serves as the WE, the CE is 
silver and the reference is a SCE. The rotating disc electrode consists of a small 
platinum disc (1cm2), which was embedded centrally within a large cylinder 
composed of teflon. The cylinder was placed in the vessel containing the reaction 
mixture and rotated at a constant speed (typically 40Hz). The cathode was 
deaerated with argon. The electrolyses were stopped when the current had 





iV-benzalaniline (cone 3.5mM) and dibromobutane (cone 35mM) were placed in 
DMF containing the supporting electrolyte (TBAHFP) (0.1M) and reduced at a 
rotating disc electrode (1cm2) for 8 h, until the current had fallen to nearly zero. 
The catholyte was then diluted with water, neutralised, extracted with ether and 
the solvent evaporated in vacuo. The electrolysis compounds were separated from 
the excess dibromoalkane by acid extraction. The title compound was obtained by 
column chromatography (O.lg, 2.0%), 5h(CDC13); 1.5-2.1 (6H, m), 3.1-3.4 (2H, 
m), 4.5 (1H, t, .7=4.5), 6.1-13 (10H, m), 6c (CDC13); 22.1 (2H), 25.6 (2H), 33.4 
(2H), 50.5 (2H), 60.9, 118.7, 119.5, 125.8, 126.1, 127.2, 128.2, 128.7, 131.5, 
143.5, 151.8.
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A typical procedure for the reductive alkylation of the indolenine (52)
A solution of indolenine (52) (cone 3.5mM) and the alkyl halide (35mM) in the 
supporting electrolyte (0.1M) was reduced at a rotating disc electrode (1cm2) until 
the current had fallen to almost zero. The catholyte was then diluted with water 
and any products extracted with ether and dried over magnesium sulfate.
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